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ABSTRACT 
Hericium erinaceus (Bull. Fr.) Pers. is a well-known culinary-medicinal mushroom that 
is used in traditional Chinese and Japanese cooking and herbal medicine to treat various 
human diseases. The objectives of the present investigation was to evaluate the 
gastroprotection and healing effects by aqueous extracts of the basidiocarps H. 
erinaceus against ethanol-induced gastric ulcers in rats. In acute toxicity study, all 
animals did not show any abnormal behavioural expressions and toxicological signs. 
Seven groups of rats were pre-treated orally with distilled water as the normal group; 
distilled water as ulcer group; 20 mg/kg of omeprazole as positive group; 50, 100, 200, 
and 400 mg/kg of extract as the experimental groups. One hour later, distilled water was 
given orally to the rats in normal group while ethanol was given orally to the ulcer 
control, positive control, and the experimental groups. The rats were sacrificed after an 
hour. Ulcer area, gastric wall mucus, gastric mucus barrier test, and histology and 
immunohistochemistry of the gastric wall were assessed. Gastric homogenates were 
analysed for Lipid peroxidation (LPO), superoxide dismutase (SOD), and catalase 
(CAT) content. The ulcer group exhibited significantly (p < 0.05) severe mucosal injury 
when compared to rats treated with omeprazole or extracts which showed significant (p 
< 0.05) protection against gastric mucosal injury. The mushroom extracts promoted 
protection as there was significant (p < 0.05) reduction of gross ulcer area. Further, the 
histological analysis showed marked reduction of edema and leucocytes infiltration in 
the submucosal layer when compared to the ulcer group. Immunohistochemistry studies 
showed up-regulation of HSP70 protein and down-regulation of Bax protein in rats pre-
treated with extract. Significant (p < 0.05) increase in the mucus of gastric content and 
high levels SOD and CAT, reduced amount of LPO was observed in rats treated with 
mushroom extracts indicating the protective and / or healing effects of the mushroom 
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extracts. During the three days ulcer treatment test, H. erinaceus extract at a dose of 
400mg/kg could significantly (p < 0.05) heal the ulcer that was induced by ethanol in 
the rats. 
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ABSTRAK 
Hericium erinaceus (Bull. Fr.) Pers. merupakan cendawan yang boleh di makan dan 
amnya  digunakan dalam  perubatan tradisional cina dan jepun untuk mengubati 
pelbagai penyakit. Objektif kajian ini adalah untuk mengkaji kesan gastroproteksi dan 
pemulihan ekstrak akues terhadap ulser gastrik berpunca dari etanol. Dalam kajian acute 
ketoksikan, semua haiwan tidak menunjukkan tingkah laku yang luar biasa dan tanda-
tanda keracunan.Tujuh kumpulan tikus diberi minum air suling sebagai kumpulan 
normal; air suling sebagai kumpulan ulser; 20mg/kg omeprazole sebagai kumpulan 
positif; dan 50, 100, 200 dan 400 mg/kg ekstrak sebagai kumpulan eksperimen. Satu 
jam kemudian, air suling diberi minum kepada tikus dalam kumpulan normal sementara 
etanol diberi minum kepada kumpulan kawalan ulser, kumpulan kawalan positif, dan 
kumpulan-kumpulan eksperimen. Tikus-tikus tersebut dikorbankan sejam kemudian. 
Kawasan ulser, mukus dinding gastrik, ujian pemisah mukus gastrik, dan histologi dan 
immunokimia dinding gastrik diperiksa. Homogenat gastrik dikesan untuk kandungan 
lipid peroxidasi (LPO), superoxide dismutase (SOD), dan catalase (CAT). Tikus- tikus 
dibawah kumpulan yang dijangkiti ulser menunjukan perubahan ketara (p < 0.05) dalam 
kecederaan mukosa yang parah berbanding dengan tikus-tikus yang dirawati dengan 
omeprazole atau kumpulan ekstrak yang menunjukkan sifat perlindungan terhadap 
kecederaan mukosa gastrik yang ketara (p < 0.05). Cendawan ini menunjukan kesan 
protektif terhadap ulser kerana ia menunjukkan pengurangan ketara kawasan ulser dan 
histologi menunjukkan pengurangan edema dan penyusupan leukosit lapisan 
submucosal berbanding dengan kumpulan ulcer. Immunohistokimia menunjukkan up-
regulation protein HSP70 and down-regulation protein Bax dalam tikus-tikus yang telah 
dirawati dengan ekstrak. Peningkatan ketara (p < 0.05) dalam mukus kandungan  gastrik 
dan paras tinggi SOD dan CAT, serta pengurangan jumlah LPO diperhatikan pada tikus 
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yang dirawat dengan ekstrak cendawan ini. Kajian terhadap ulser telah dijalankan 
selama tiga hari dan ekstrak H. erinaceus (400mg/kg) menunjukkan kebolehan untuk 
menyembuhkan ulser dalam kumpulan tikus yang telah diberikan etanol.    
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1.0 Introduction  
Peptic ulcers, including both gastric and duodenal ulcers, have been a major 
threat to the world’s population over the past two centuries. In 2007, roughly 14.5 
million people in the United States suffered from peptic ulcers, and this number had 
increased further to 14.99 million by year 2010. (Pleis et al., 2009; and Schiller et al., 
2012). The two most common types of peptic ulcers are named after the location where 
the ulcer is found. Gastric ulcers are located in the stomach, whereas duodenal ulcers 
are found at the beginning of the small intestine or duodenum.  
The predominant symptom of uncomplicated peptic ulcer is epigastric pain, 
which presents itself with other symptoms such as fullness, bloating, early satiety, and 
nausea. Generally, patients with duodenal ulcers suffer epigastric pain during the fasting 
state or even during the night, and this is usually relieved by food intake or acid-
neutralising agents (Malfertheiner et al., 2009). Gastric ulcers are a serious 
gastrointestinal (GI) disorder, and occur when the gastric mucosa is impaired, leading to 
perforations of the stomach lining and then bleeding. 
Generally, peptic ulcers result from an imbalance between increased aggressive 
factors in the body, such as acid and pepsin secretions (Wolfe & Sachs, 2002), and 
decreased defensive factors, such as mucus and bicarbonate secretions (Allen & 
Flemstrom, 2005), mucosal barriers (Peskar, 2001), mucosal blood flow (Abdel-Salam 
et al., 2001) and endogenous prostaglandin production (Peleg & Wicox, 2002). Some 
other factors which induce peptic ulcers include Helicobacter pylori infections (Peura, 
1997), the ingestion of non-steroidal anti-inflammatory drugs (NSAID) (Pawlik et al., 
2000), and psychological stress (Brogie, 1962). The production of free radicals, 
inhibition of cell proliferation, and infiltration of inflammatory cells are also factors 
involved in the pathogenesis of ulcers (Maity & Chattopadhyay, 2008). Many 
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ulcerogens produce excessive reactive oxygen species (ROS), which cause imbalances 
between aggressive and protective factors such as levels of cytokines, prostaglandins 
(PGs) and enzymes (COXs, NOS etc.), pro- and anti-angiogenic as well as tissue 
growth parameters. 
The objectives of treatment for peptic ulcers are relief from pain, enhancement 
of healing and prevention of recurrence. Treatment for stomach and duodenal ulcers is 
decided by the doctor on the basis of a patient’s age; overall health; medical history; 
extent of the pathogenesis; tolerance for medications, procedures or therapies; and 
expectations or preferences. Therapeutic strategies generally aim to restore balance 
between aggressive and defensive factors. In the past, the major therapies mainly aimed 
to reduce the secretion of gastric acids, which were considered as the main cause of 
ulcer formation. Nowadays, treatment strategy has changed to focusing on potentiating 
the mucosal defences along with reducting acid secretions (Wallace, 2005). 
Anti-secretory agents as H2-receptor antagonists and proton pump inhibitors and 
mucosal protective agents as sucralfate and prostaglandin analogs are very important 
drugs for the treatment of peptic ulcers. At the same time, each of these drugs can cause 
simpler to serious side effects like gynaecomastia that occurs with cimetidine (H2-
receptor antagonist) (Brogden et al., 1978) and enterochromaffin-like cell (ECL) 
hyperplasia that occurs in omeprazole (proton pump inhibitor) treatments (Ekman et al., 
1985). Hence the interest of researchers in finding better and safer alternatives for the 
treatment of peptic ulcers and specifically in the gastroprotective effects of medicinal 
plants which may have fewer side effects. 
Nowadays, natural products have not only gained a strong foothold in the 
pharmaceutical industry but have also inspired the search for new potential sources of 
bioactive molecules (Schmeda-Hirschmann & Yesilada, 2005). Herbs, medicinal plants, 
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spices, vegetables, and crude drug substances are considered potential resources in the 
fight against various diseases, including gastric ulcers. Some medicinal plants such as 
ginger (Yamahara et al., 1988), turmeric (Rafatullach et al., 1990) and aloe (Suvitayavat 
et al., 1997) are reported to have gastroprotective effects. Abdulla et al. (2008) reported 
that Hericium erinaceus, one of the well-known medicinal mushrooms, produced 
gastroprotective activity in rats. 
Medicinal mushrooms have a history of applications in traditional oriental 
therapies. Mushroom-derived preparations continue to be used in modern clinical 
practice in countries such as Japan, China and Korea. Medicinal effects have been 
proved for many traditionally used mushrooms (Ooi & Liu, 2000), including extracts 
from species belonging to the genera Auricularia, Flammulina, Ganoderma, Grifola, 
Hericium, Lentinula, Pleurotus, Trametes (Coriolus), Schizophyllum, and Tremella 
(Wasser, 2002). Over the past twenty to thirty years, scientific and medical studies in 
Japan, China, Korea, and more recently in the United States, India and Malaysia, have 
increasingly demonstrated the potent and unique properties of mushroom-extracted 
compounds for the prevention and treatment of cancer.  
Hericium erinaceus, a spine fungus which grows on the trunks, branches and 
stumps of trees, can be found throughout the northern hemisphere, and range from rare 
in central Europe to fairly common in southern England (Pegler, 2003). This mushroom 
not only tastes extremely good, but also several medicinal properties have been 
attributed to it. Previous studies have reported anti-tumor activities (Mizuno et al., 
1995), antioxidant properties (Wong et al., 2007), antimicrobial effects (Wong et al., 
2009a), the stimulation of neurite outgrowth in the cell line NG 108-15 (Wong et al., 
2009b) and nerve regeneration (Wong et al., 2011). 
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Hericium erinaceus is a temperate mushroom that has been domesticated and is 
commercially grown in Malaysia. The extracts of this mushroom have both neurite-
outgrowth stimulating effects (Wong et al., 2009b) and preliminary study had shown 
that gastric ulcer prevention effects of this mushroom (Abdulla et al., 2008). In the 
current study, extracts of tropical grown H. erinaceus were investigated to establish 
whether and how these have gastric ulcer prevention and healing effects.  
The objectives of this study were to:  
a) investigate the gastroprotective and ulcer healing properties of H. erinaceus. 
b) measure the lipid peroxidation and antioxidant enzymes in gastric ulcers in a 
rat’s stomach, induced by ethanol. 
c) evaluate the effects of ethanol and H. erinaceus extract on HSP70 and Bax 
proteins in immunohistochemical staining. 
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2.0 Literature review 
2.1  Gastric Ulcers 
2.1.1 Anatomy of human stomach 
The stomach is the most dilated part of the digestive tube, having a capacity of 
1000–1500 ml in adults. It is located between the end of the oesophagus and the 
duodenum – the beginning of the small intestine. It lies in the epigastric, umbilical, and 
left hypochondrial regions of the abdomen, and occupies a recess bounded by the upper 
abdominal viscera, the anterior abdominal wall and the diaphragm. It has two openings 
and is described as having two borders, although in reality the external surface is 
continuous. The relationship of the stomach to the surrounding viscera is altered by the 
amount of the stomach contents, the stage that the digestive process has reached, the 
degree of development of the gastric musculature, and the condition of the adjacent 
intestines. However, borders are assigned by the attachment of the peritoneum via the 
greater and lesser omentum, thus dividing the stomach into an anterior and posterior 
surface (Daniels & Allum, 2005). 
 
The main function of the stomach is to mix food with acid, mucus and pepsin 
and then release the resulting chyme, at a controlled rate, into the duodenum for the 
process of absorption. Gastric motility is controlled by both neural and hormonal signals. 
Nervous control originates from the enteric nervous system as well as the 
parasympathetic (predominantly vagus nerve) and sympathetic systems. A number of 
hormones have been shown to influence gastric motility: gastrin and cholecystokinin, 
for example, act to relax the proximal stomach and enhance contractions in the distal 
stomach. Other functions of the stomach include the secretion of intrinsic factors 
necessary for the absorption of vitamin B12 (Daniels & Allum, 2005). 
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The stomach wall is made of four layers: mucosa, submucosa, muscularis 
externa and serosa. The mucosa is the innermost layer, and is divided into a surface 
epithelium, a loose connective tissue called lamina propria, and a thin smooth muscle 
called muscularis interna or muscularis mucosae. The submucosa is the loose 
connective tissue, containing blood vessels and nerve endings. The muscularis externa 
is the muscular layer, consisting of an inner oblique muscle, a middle circular muscle 
and an outer longitudinal muscle. Finally, the serosa is the outermost layer (Marieb, 
1998). 
 
2.1.2 Rat stomachs 
The rat’s stomach comprises two regions: the non-glandular (forestomach) and 
glandular parts. The non-glandular stomach is lined by cornified squamous epithelium. 
The glandular stomach consists of the corpus, antrum and pyrolus, and is lined by a 
simple columnar epithelium. The non-glandular part is distinguished from the glandular 
part of the stomach by the limiting ridge, which prevents a reflux of gastric juice from 
the glandular part into the non-glandular part when the stomach is empty. The anatomy 
and physiology of a rat’s stomach is not much different from the human stomach. There 
has been a considerable volume of research using the rat’s stomach as tools to 
investigate the gastric function, so the results from rat models provide the basic 
information on humans as well (Sbarbati et al., 1995). 
 
2.2 Peptic ulcer and gastric ulcer diseases 
There are various kinds of ulcers, named after their respective locations in the 
digestive tract. Duodenal or peptic ulcers can be found in the intestines, while gastric 
ulcers are located inside the stomach. A gastric ulcer is considered as a necrotic lesion 
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penetrating through the entire mucosal thickness of the stomach. Peptic and duodenal 
ulcers are usually benign; however, gastric ulcers are more prone to becoming 
malignant. In this study, we focus on gastric ulcers induced by ethanol. 
 
2.3 Factors that cause peptic ulcers 
Peptic ulcers form because of an imbalance between increased aggresive factors, 
which breakdown the ability of the gastrointestinal mucosa to protect itself, and a 
decrease in the defensive factors which maintain mucosal integrity through endogenous 
defense mechanisms. These aggressive and defensive factors and their roles in peptic 
ulcers are described below: 
 
2.3.1 Aggresive factors 
 
2.3.1.1 Helicobacter pylori (H. pylori) 
 
Helicobacter pylori is a spiral-shaped, pH-sensitive, gram-negative, 
microaerophilic bacterium that arises between the mucous layer and surface epithelial 
cells in the stomach. The ability of H. pylori to produce urease may be related to its 
pathogenic potential and survival in the stomach. Urease is an enzyme which can break 
down urea into carbon dioxide and ammonia. The ammonia is converted into 
ammonium by taking away a proton (H
+
), leaving only hydroxyl ions. The hydroxyl 
ions then react with carbon dioxide, producing carbonate, which neutralizes gastric acid. 
Urease activity is low at neutral pH but can increase 10- to 20-fold as the external pH 
falls to between 6.5 and 5.5, and remains high at pH 2.5 (Scott et al., 1998). 
Helicobacter pylori also carry another protein – urel, which is a urea transporter that 
brings urea into the cytoplasm of the bacteria for urease to digest. Helicobacter pylori 
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cause gastric mucosal injury by direct effects, by changes in immune/inflammatory 
responses and by hypergastrinemia leading to increased acid secretions. Helicobacter 
pylori infections change inflammatory responses and damage epithelial cells directly by 
cell-mediated immune mechanisms or indirectly by activated neutrophils or 
macrophages attempting to phagocytose bacteria or bacterial products (Peura, 1997). 
 
2.3.1.2 Nonsteroidal anti-inflammatory drugs (NSAID) 
NSAIDs cause clinically significant ulceration, bleeding, or obstruction in 1–4% 
of patients chronically taking these drugs (Silverstein et al., 2000). NSAIDs inhibit 
cyclooxygenase (COX), the enzyme responsible for the conversion of arachidonic acid 
to prostaglandins (Vane, 1971). There are two isoforms of COX: COX-1 and COX-2 
(Crofford et al., 2000). COX-1 is a ubiquitous constitutive isozyme producing 
prostaglandins responsible for maintaining gastrointestinal mucosal integrity, vascular 
homeostasis and renal functions (Crofford et al., 2000). COX-2 is a largely cytokine-
induced iso-zyme producing prostaglandins that are associated with pain and 
inflammation (Crofford et al., 2000). NSAIDs inhibit both COX-1 and COX-2 to 
varying degrees (Gierse et al., 1995; and Gierse et al., 1999). Gastric injuries induced 
by NSAIDs are shown in Figure 2.1. 
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Figure 2.1: The pathogenesis of NSAID-induced gastric injury and bleeding. NSAIDs induce 
injury/bleeding via three key pathways: inhibition of cyclooxygenase (COX)-1 activity, inhibition of 
COX-2 activity, and direct cytotoxic effects on the epithelium. Effects produced via only one of these 
pathways (e.g. the selective inhibition of COX-1 and COX-2) are unlikely to produce significant damage 
(retrieved from Wallace, 2008).  
 
Gana et al. (1987) reported that NSAIDs have the ability to reduce blood flow 
on the gastric mucosa. A reduction of gastric blood flow is usually not sufficient to 
result in significant mucosal injury. However, reduced mucosal blood flow can lead to 
the mucosa becoming more vulnerable to damage induced by luminal irritants, and 
damage the epithelial restitution process (Wallace & McKnight, 1990). 
 
2.3.1.3 Stress 
Psychological and physical stresses have both been shown to precipitate 
mucosal injury in animal models of peptic ulcer disease (Weiner, 1991). Stress ulcers 
are frequently seen in intensive care settings after surgery for various acute and severe 
diseases. The resulting pathophysiology interferes with blood flow and sporadic acid 
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secretions, and disrupts mucosal defences. Incubation, which is a common procedure 
during major surgery (especially cardiac, neural, or renal transplants), and major trauma, 
such as bum or spinal cord injury, increase the chances of patients getting peptic ulcer 
disease (Soll, 1989). 
 
2.3.1.4 Smoking 
 
Previous studies (Hull & Beale, 1985) have proved that cigarette smoking is an 
important risk factor which can cause peptic ulceration and delayed ulcer healing. 
However, the mechanism through which ulceration develops due to cigarette smoking 
still remains unclear. 
 
2.3.2 Defensive factors 
 
2.3.2.1 Mucosal defense 
The term “mucosal defense” describes the various factors and components that 
permit the mucosa to remain intact despite frequent exposure to substances with a wide 
range of temperatures, pHs, and osmolarity, as well as to substances with detergent or 
cytotoxic actions, and bacterial products capable of causing local and systemic 
inflammatory reactions (Wallace & Granger, 1996). The gastric mucosa is not 
impermeable to damage by these agents, and mucosal injuries do occur reasonably 
regularly. However, the ability of the mucosa to repair itself rapidly can limit these to 
the most superficial layer of cells and prevent entry into the systemic circulation of 
substances detrimental to the organism. In a healthy organism, the resistance of the 
gastric mucosa to injury is increased when the stomach is irritated by certain factors, for 
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instance through an increment of mucosal blood flow and an efflux of mucus from 
surface epithelial cells.  
 
2.3.2.2 The Epithelium  
 
The epithelium is often described as the physical barrier of stomach. There are 
various components of mucosal defense on the luminal side of the epithelium, including 
gastric juice and mucus. Gastric juice has a number of constituents capable of 
decreasing bacterial colonization of the stomach, including acid, immunoglobulins, and 
lactoferrin. Giannella et al. (1973) demonstrated that acid is an important defensive 
factor, and that hypochlorhydria and achlorhydria can therefore increase the risks and 
exacerbate the severity of bacterial and certain parasitic infections.  
The mucus that is secreted onto the surface of the stomach plays a number of 
roles:  as a lubricant, to reduce physical damage to the epithelium by ingested materials, 
and as a trap for bacteria (Forstner, 1978; and Belley et al., 1999). Thus mucus can 
decrease the ability of bacteria to enter into the epithelium. Mucus creates an unstirred 
layer on the mucosal surface, which helps to maintain a near-neutral pH at that surface 
as well as acting as a physical barrier against luminal pepsin (Allen & Flemström, 2005). 
Schreiber and Scheid (1997) suggested that mucus retard the diffusion of protons, which 
can further help in maintaining a favourable pH at the apical surface of the epithelium.  
Hills et al. (1983) reported that the surface of the stomach is hydrophobic, and 
therefore a barrier to acid back-diffusion, because of the presence of a surfactant-like 
layer of surface-active phospholipids. This layer is located either on the surface of the 
epithelium itself, or on the most luminal surface of mucus overlying the epithelium 
(Goddard et al., 1990). Aspirin or bile salts cause disruption in this layer, resulting in an 
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elevated diffusion of acid into the mucosa, and to mucosal necrosis (Goddard et al., 
1990). 
Although there are several “layers” of mucosal defense, experimentally reducing 
the effectiveness of the mucus-bicarbonate layer on the epithelial surface does not 
usually result in epithelial damage (Wallace, 1989). It is possible that may have an 
underlying ability to remain intact and functional when continuously exposed to high 
concentrations of acid. Sanders and colleagues (1985) reported that the apical 
membrane of cultured chief cells is highly resistant to damage by acid and that these 
cells can tolerate a solution of pH 2 for more than four hours without any damage to the 
cells. Takezono et al. (2004) revealed that gastric-surface mucus cells have a 
mechanism to resist the back-diffusion of acid into the mucosa that involves 
enhancement of the functional barrier. 
 
2.3.2.3 Mucosal blood flow 
Mucosal blood flow is triggered by sensory afferent neurons when irritants such 
as acid enter the subepithelial compartment, allowing the buffering of acid and the rapid 
removal of toxic substances, thus limiting the latter’s penetration into deeper layers of 
the mucosa (Wallace & Granger, 1996). When the sensory afferents are stimulated, this 
causes a rapid increase in mucosal blood flow. Holzer and Sametz (1986) reported that 
excision of the sensory afferent neurons eliminates the “reactive hyperemic” response to 
topical irritants and thereby increases the chances of injury to the gastric mucosa. A 
constant delivery of plasma from the subepithelial blood vessels plays an important role 
in maintaining a repair-conducive microenvironment. An interruption in blood flow can 
result in a rapid decrease in pH at the site of the injury, leading to disruption of the 
repair process and damage progressing to deeper layers of the mucosa (Wallace & 
McKnight, 1990). 
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2.3.2.4 Ulcer healing 
 
Healing a gastric ulcer requires restoring the epithelium, endothelium, 
connective tissue, and smooth muscle damaged during ulceration. Ulcer healing is a 
complex repair process that involves inflammation, cell proliferation (particularly at the 
ulcer margin), the formation of granulation tissue at the base of the ulcer, and 
angiogenesis (new blood vessel growth).  
Normally, intestinal epithelial repair after injury involves different processes 
which can be considered partially independent (Figure 2.2). The initial, rapid response 
to damage involves the migration of surrounding epithelial cells to cover the denuded 
area (Argenzio et al., 1988; Lacy, 1988; and Feil et al., 1989) - a process called re-
epithelialization. This process is crucial because a continuous epithelial “barrier” can 
protect granulation tissue from mechanical and chemical injury or infection. For small 
wounds, short restitution and proliferation phases may be sufficient to restore the 
monolayer. If the wound is large, immunologic responses and the deposition of 
protective granulation tissue may be necessary to restore epithelial continuity.  
The re-epithelialization process involves epithelial cell migration and 
proliferation, and is activated and regulated by certain growth and transcription factors 
(Tarnawski, 2000; Vanwijck, 2001; and Chai et al., 2004). 
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Figure 2.2: The basic processes of intestinal epithelial wound healing. When an undamaged mucosal 
surface (A) is subjected to an attack that strips away epithelial cells (B), the first response is loss of 
polarization of cells near the wound margin and conversion to a migratory phenotype (C). Over a process 
of minutes to hours, depending on the extent of the wound, cells flatten and move to cover the denuded 
area, re-establishing the protective barrier (D). Leader and follower cells often move as a unified sheet, 
maintaining rudimentary attachments during the restitution process. Cell proliferation restores the 
epithelial population (E), allowing cells to reform normal junctional complexes and retrieve a polarized 
columnar phenotype (F). (Frey & Polk, 2006) 
 
Granulation tissue develops at the ulcer base two or three days after ulceration 
[(Tarnawski et al., 1990; Tarnawski et al., 1991; Tarnawski, (1993, 2000); and Cotran 
et al., 1999)]. Proliferating connective tissue cells such as macrophages, fibroblasts and 
proliferating endothelial cells found in granulation tissue form microvessels through the 
process of angiogenesis [(Tarnawski et al., 1990; Tarnawski et al., 1991; Tarnawski, 
(1993, 2000); and Cotran et al., 1999)]. Granulation tissue plays a crucial role in the 
ulcer healing process because it supplies connective tissue cells (a synthesizing 
extracellular matrix for restoring the lamina propria) and microvessels for the 
restoration of the microvasculature within an ulcer scar [(Tarnawski et al., 1991; 
Tarnawski, (1993, 2000); and Cotran et al., 1999)]. 
15 
 
Angiogenesis is the process for forming a new microvascular network, which is 
considered essential for the healing of chronic gastroduodenal ulcers. Angiogenesis 
happens through a series of steps, which include: (a) degradation of the capillary 
basement membranes by matrix metalloproteinases; (b) endothelial cell migration into 
the perivascular space and proliferation; (c) the formation of microvascular tubes 
followed by anastomoses; (d) the establishment of lumina and basement membranes; 
and finally, (e) the formation of the capillary network (Tarnawski et al., 1991; Folkman 
& D’Amore, 1996; Risau, 1997; and Cotran et al., 1999). The formation of granulation 
tissue and generation of new microvessels through angiogenesis is induced by bFGF, 
VEGF, PDGF, angiopoietins, and other growth factors and cytokines, including IL-1 
and tumor necrosis factor-alpha (TNF-α) (Folkman & D’Amore, 1996; Risau, 1997; and  
Tarnawski, 2000). 
Extracellular matrix (ECM) is secreted by a wide range of cell types including 
fibroblasts, epithelial, smooth muscle and endothelial cells. It assembles into a network 
in the spaces surrounding cells which withdraws water and minerals and binds growth 
factors (Basson et al., 1993; Cotran et al., 1999; and Basson, 2001). ECM consists of 
fibrous structural proteins such as the collagens and elastins, adhesive glycoproteins 
including fibronectin and laminin and an amorphous gel composed of proteoglycans and 
hyaluronan. All the components above can form an interstitial matrix as well as the 
basement membrane (Basson et al., 1993; Cotran et al., 1999; and Basson, 2001). 
The replacement of granulation tissue with a connective tissue scar changes the 
composition of the ECM. These growth factors not only stimulate the production of 
collagen and other connective tissue components but also modulate the synthesis and 
activity of metalloproteinases- enzymes which degrade these ECM components (Cotran 
et al., 1999). The end result of this process is a remodelling of the connective tissue, 
which is an important feature of ulcer healing (Cotran et al., 1999). Degradation of the 
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collagen and other ECM proteins is accomplished by the matrix metalloproteinases, 
enzymes dependent on zinc ions for their activity (Pai et al., 1998; Cotran et al., 1999; 
and Calabro et al., 2004).  Some collagenases and their inhibitors are essential in the 
remodelling of connective tissue required for tissue defect repair and scar formation (Pai 
et al., 1998; and Calabro et al., 2004). 
 
2.4 Medical treatment of gastric ulcer disease 
Treatment of gastric ulcer disease usually involves a combination of antacids 
(aluminium hydroxide, magnesium hydroxide) (Preclik et al., 1989), H2-receptor 
antagonists (e.g. cimetidine, famotidine, nizatidine, ranitidine) (Rainford, 1987), proton 
pump inhibitors (e.g. omeprazole, lansoprazole) (Sander, 1996), and complex bismuth 
salt (e.g. colloidal bismuth subcitrate (CBS)) (Tytgat, 1986). Unfortunately, patients 
have to take as many as 20 pills a day, and often end up with different side effects, 
which can range from nausea to vomiting, diarrhea, dizziness and headaches. 
 
2.4.1 Omeprazole  
Omeprazole is a proton pump inhibitor that suppresses gastric acid secretion by 
specific inhibition of the H+/K+- ATPase in the gastric parietal cell. By acting 
specifically on the proton pump, omeprazole blocks the final step in acid production, 
therefore decreasing gastric acidity. The structure of omeprazole is shown in Figure 2.3. 
 
 
 
 
 
17 
 
 
 
 
Figure 2.3: Chemical structure of omeprazole 5-methoxy-2-[(4-methoxy-3,5-dimethyl-pyridin-2- 
yl)methylsulfinyl]-3H-benzoimidazole (Singh, 2008). 
 
2.4.2 Characteristics of Omeprazole 
  Omeprazole has some unique features and charcteristics that are important for 
the way it works. First of all, omeprazole is lipophilic and can easily penetrate cell 
membranes. Second, omeprazole is a weak base, which means that it concentrates in 
acid compartments. Third, omeprazole is unstable in an acidic solution. The half-life of 
omeprazole at pH 1 is approximate two minutes; yet when it is exposed to a neutral 
solution, that is pH 7.4; it can last for about 20 hours. Omeprazole is thus a drug that 
accumulates within the acid space of the target cell, where it is transformed into an 
active inhibitor.  
2.4.3 Limitations of Omeprazole 
Toxicological studies using very high doses of omeprazole in rats showed that 
this could lead to the formation of endocrine tumours (carcinoids) in the stomach. The 
carcinoids arose from entero-chromaffine-like (ECL) cells, a type of endocrine cell in 
the gastric mucosa that synthesizes and produces histamine, a process stimulated by the 
gastric hormone gastrin (Larsson et al., 1986). At the same time, longer term 
stimulation by gastrin has a massive effect on ECL cells. As the amount of gastrin 
increases and acid secretions decrease, this effect can result in the elimination of gastric 
acid secretions, leading to massive hypergastrinemia (Mattsson et al., 1991). 
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2.5 Mushrooms  
2.5.1 Introduction to mushrooms 
Nowadays, there are at least 80,060 species of described fungi of all kinds on the 
Earth. This figure is based on the total derived from adding together the species in each 
genus given in the latest edition of the Dictionary of Fungi (Kirk et al., 2001), which 
includes all organisms traditionally studied by mycologists: slime molds, chromistan 
fungi, chytridiaceous fungi, lichen-forming fungi, filamentous fungi, moulds and yeasts. 
From the definition of Chang and Miles (1992), ‘a mushroom is a macrofungus 
with a typical fruiting body which can be hypogeous or epigeous, large enough to be 
seen with the naked eye and to be picked by hand’. The number of filamentous fungi 
that are mushrooms, in the sense of this definition deduced from the Dictionary of the 
Fungi, is at least 14,000 and perhaps as many as 22,000 (Hawksworth, 2001). That, the 
actual number of such species on Earth is probably much higher is due to two main 
reasons: (1) the large number of as yet undescribed species; and (2) the fact that many 
morphologically defined mushroom ‘species’ prove to be assemblages of several 
biological species (Hawksworth, 2001). Potentially new mushrooms are regularly found 
in the tropics, especially species forming ectomycorrhizas with native trees. In various 
tropical areas, 22–55% (in some cases up to 73%) of mushroom species have turned out 
to be undescribed (Hawksworth, 2001). An analysis of the localities from which fungi 
new to science have been described and catalogued in the Index of Fungi in the 10 years 
from 1990 to 1999 revealed that about 60% of all newly identified fungi were from the 
tropics (Hawksworth 1993, 2001); and this is also the case for mushrooms, although 
new species also continue to be discovered in Europe and North America. 
Researches of compatibility and molecular sequences between mushrooms 
previously considered to be the same species on morphological grounds have revealed 
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‘cryptic species’, i.e., populations functioning as separate biological species but covered 
by a single scientific name. Hawksworth (2001) stated that a single morphologically 
identified species may consist of 20 or more biological species. Given this, the number 
of fungi species on Earth could range from 500,000 to as many as 9.9 million, of which 
only 80,060 have been named. A working figure of 1.5 million species is generally 
accepted, and new data suggests that this is not unreasonable. Within this, the number of 
mushrooms on Earth is estimated at 140,000, of which maybe only 10% are known. 
Meanwhile, of those nearly 14,000 species that we know today, around 50% are 
considered to have varying degrees of edibility; just over 2,000 are safe; and about 700 
are known to possess significant pharmacological properties (Chang, 1999; Wasser & 
Weis 1999; and Reshetnikov et al., 2001). Hence, it is clear that mushrooms represent a 
major potential source of powerful new pharmaceutical products.  
 
2.5.2 Hericium erinaceus 
Hericium erinaceus (Bull. Fr.) Pers. is known as monkeyhead mushroom in 
China, and ‘cendawan bunga kobis’ in Malaysia. Other common names for Hericium 
spp. included lion’s mane, old man’s beard, hedgehog mushroom, satyr’s beard, pom 
pom and yamabushitake (Japanese for “mountain-priest mushroom”)(Stamets, 2005). 
The basidiocarp of H. erinaceus appears as a slightly rounded structure, up to 25 
cm in diameter; pure white when fresh, but easily becoming bruised and staining 
yellowish brown (Figure 2.4). There is no recognizable cap, but only a short stalk from 
which grows a cascade of long, downwardly projecting spines, up to 4 cm long. In 
nature, the fruit body always grows out of the knotholes or wounds of a tree, which may 
be walnut, oak, elm, or beech. In the wild, only the fresh, young fruit body is edible and 
is regarded as a delicacy- an especially desirable one, as the fruit body can be large. 
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When this mushroom becomes old and yellowish brown, the taste can turn bitter and 
unpleasant (Pegler, 2003). 
 
Figure 2.4: Basidiocarp of Hericium erinaceus. (Source: retrieved from  
    Prof. Dr. Vikineswary Sabaratnam, University of Malaya) 
 
Because of the rapid increase of interest in Hericium species, more information 
about this mushroom is necessary to screen efficient species and strains, and to improve 
its yield and quality. Unfortunately, limited data and reference texts are available on the 
physiological, genetic, and cultural characteristics of the Hericium species. To date, 
only a few Hericium species have been identified throughout the world. Park et al. 
(2004) analyzed the phylogenetic relationships of seven Hericium species including H. 
abietis, H. alpestre, H. americanum, H. coralloides, H. erinaceum, H. erinaceus and H. 
laciniatum. Among the seven Hericium species, attempts at cultivation on logs, stumps 
and sawdust have been made so far only with H. erinaceum (Suzuki & Mizuno, 1997), 
H. erinaceus (Chang & Roh, 1999) and H. abietis (Xiao & Chapman, 1997). Ko et al. 
(2005) studied the potential for using agricultural by-products as a supplementary 
resource of sawdust substrate for the growth of seven Hericium species, as well as 
basidiomata formation and production on oak sawdust substrate. 
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2.5.3 Medicinal properties of H. erinaceus 
Mizuno (1999) found that polysaccharides (HEPS) in the fruiting bodies of 
Hericium erinaceus may have beneficial effects against stomach, esophageal and skin 
cancers. Hericium erinaceus (including its fruiting body, mycelium, and products in the 
medium) also contains some lower-level MW pharmaceutical constituents, such as the 
novel phenols (hericenones A and B) and Y-A-2, which may have chemotherapeutic 
effects on cancer. Yang et al. (2003) studied the hypolipidaemic effect of an exo-
biopolymer produced from a submerged mycelial culture of H. erinaceus in dietary-
induced hyperlipidaemic rats. After oral administration of exo-biopolymer at a dose of 
200 mg/kg of body weight, the plasma total cholesterol (32.9%), low density lipoprotein 
cholesterol (45.4%), triglyceride (34.3%), phospholipids (18.9%), atherogenic index 
(58.7%) and hepatic HMG-CoA reductase activity (20.2%) were extensively reduced. It 
also increased the plasma high density lipoprotein cholesterol level (31.1%) over that of 
the control group (Yang et al., 2003). 
Recent studies have determined that H. erinaceus may have important 
physiological functions in humans, including antioxidant activities, the regulation of 
blood lipid levels and reducing blood glucose levels (Chyi et al., 2005). Gue et al. (2006) 
stated that H. erinaceum is a medicinal and edible mushroom with anti-microbial and 
anti-cancer activities.  
Recently, Hericium spp. has attracted considerable attention from researchers 
owing to its antimicrobial effects (Kim et al., 2000), anti-tumor activities (Mizuno et al., 
1995), immunomodulatory effects (Liu et al., 2002), antioxidant properties (Mau et al., 
2002), cytotoxic effects (Kuwahara et al., 1992), and promotion of synthesis of 
neurogrowth factors (Kawagishi et al., 1994).  
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2.5.4 Nutritional composition of H. erinaceus 
Wang et al. (1992) studied the nutritional composition of five strains of H. 
erinaceus fruit bodies that have the highest crude protein content (28.4%) and low crude 
fat. Kim et al. (2011) found that, for four H. erinaceus extracts, protein, carbohydrate, 
and mineral (ash) content were all high, ranging (in % of dry weight) from 35.5 to 38.5; 
33.8 to 39.5 and 14.6 to 19.0 respectively; moisture content was about 8%; while ﬁber 
and fat content were <1%. 
 
2.6 Free radicals 
 
2.6.1 Introduction to free radicals 
A free radical is any chemical species capable of independent existence that has 
one or more unpaired electrons. Free radicals are often described by the insertion of a 
radical dot (·) to indicate that one or more unpaired electrons is present. Usually, 
radicals are less stable than nonradicals, in that they can interreact either with another 
radical or with another molecule in various ways to achieve a stable state. 
 
2.6.2 Reactive oxygen species 
Aerobes require oxygen (O2) to perform cell functions, as oxygen plays an 
important role in a series of biochemical reactions such as electron transport chains and 
other enzyme systems. A series of electron transfer reactions produces several 
molecules of adenosine triphosphate (ATP), which in turn provides the energy required 
for a multitude of cellular reactions and functions for each electron that passes through 
the respiratory chain. Molecular oxygen can pair with four electrons, one at a time, and 
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the corresponding number of protons to yield two molecules of water. Different oxygen 
radicals are formed as intermediate products during this process, namely superoxide (O2
-
); peroxide (O2
=), which normally exists in cells as hydrogen peroxide (H2O2); and the 
hydroxyl radical (•OH). Superoxide, peroxide, and the hydroxyl radical are considered 
the primary reactive oxygen species (ROS). Reactive oxygen species (ROS) is often 
used to refer not only to the radicals OH·, RO2·, NO· and O2·
−
, but also the nonradicals 
HOCl, 
1
O2, ONOO
−
, O3, and H2O2. 
An imbalance between the production of ROS and the activity of the antioxidant 
defences is called oxidative stress. Oxidative stress, superoxide production and an 
imbalance in antioxidant enzymes may contribute to the initiation of cancer (Wiseman 
& Halliwell, 1996), cause structural alterations in DNA (Halliwell & Aruoma, 1991), 
aﬀect cytoplasmic and nuclear signal transduction pathways (Burdon, 1995). 
 
2.6.3 Antioxidants 
An antioxidant is defined as any substance that, when present at low 
concentrations compared with those of the oxidizable substrate, considerably delays or 
inhibits oxidation of the substrate (Gutteridge, 1995). Antioxidants can act by: (a) 
removing oxygen or decreasing local oxygen concentration; (b) removing catalytic 
metal ions; (c) removing key reactive oxygen species such as superoxide and hydrogen 
peroxide; (d) scavenging initiating free radicals such as hydroxyl, alkoxyl, and peroxyl 
species; (e) breaking the chain of an initiated sequence; or (f) quenching or scavenging 
singlet oxygen (Gutteridge, 1995). 
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2.6.4 Antioxidant compounds 
Vitamin C (ascorbic acid) is a major aqueous-phase antioxidant, and Vitamin E 
(α-tocopherol) is a major membrane bound antioxidant. These compounds are both 
human vitamins that play vital roles in maintaining health. 
There are two types of antioxidant: water-soluble and lipid-soluble antioxidant 
compounds. Water-solubles include uric acid, glutathione and ceruloplasmin. Uric acid 
is the end product of purine metabolism in humans, and may function both as a classic 
suicidal antioxidant and as a chelator of transition metals. Uric acid may inhibit metal-
catalyzed oxidation reactions without itself becoming oxidized, by binding iron and/or 
copper. Beta-carotene and ubiquinone are lipid-soluble agents that may also play 
important antioxidant roles in vivo. 
 
2.6.5 Antioxidant Enzymes 
In order to minimize oxidative damage, aerobic organisms also produce 
numerous antioxidant enzymes (Fridovich, 1995; and Özben, 1998). One of the best 
known of these enzymes is superoxide dismutase (SOD).  
Superoxide dismutase (SOD) catalyzes the dismutation reaction of O2
-
 + O2
-
                            
H2O2+O2 and increases the rate constant of this important dismutation reaction 
several-fold. SOD is found in almost all eukaryotic cells, including yeasts, plants and 
animals. Different members of the SOD family use different transition metals such as 
Ferum, Manganese, Copper/ Zinc at their active sites. Bacteria use a Fe-SOD and a Mn-
SOD, whereas mammals apply distinct cytoplasmic and extracellular forms of Cu/Zn-
SOD and a mitochondrial Mn-SOD which is closely related to bacterial Mn-SOD. Mn-
SOD has four subunits, with Mn in each subunit (Smith & Heath, 1976). Cu/Zn-SOD 
consists of two subunits, with each unit having an active site containing one Cu ion and 
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one Zn ion (McCord, 1979). Cu ion serves as an active redox site while Zn maintains 
the protein structure (Fridovich, 1975). Cu/Zn-SOD is found mainly in cytosol and is 
shown to be present in the nucleus also (Slot et al., 1986). SOD present in our body can 
dismutate O2
-
 rapidly at the site where it is formed. 
The product of SOD is H2O2, which is clearly toxic and must be quickly 
removed. In mammalian cells this is accomplished by two enzyme families: the 
glutathione peroxidases and the catalases. Both glutathione peroxidases and catalases 
detoxify H2O2 by reducing it to water and oxygen. Glutathione peroxidase is not further 
discussed here. 
Catalase removes H2O2 and generates O2, 2H2O2        2H2O + O2 (Krall et al., 
1988). In most mammalian cell types, catalase is only found within peroxisomes where 
it has a clear function of removing the H2O2 generated by β-oxidation of long-chain 
fatty acids. Normally, catalase is not found in the cytoplasm of most mammalian cells, 
and for that reason diffusion of H2O2 from the cytoplasm into peroxisomes seems rather 
unconvincing all of which suggests that glutathione peroxidases largely deal with 
cytoplasmic H2O2 and catalases largely deal with peroxisomal H2O2. 
 
2.6.6 Lipid peroxidation activity 
The free-radical oxidation of polyunsaturated fatty acids in biological systems is 
known as lipid peroxidation. Lipid peroxidation is an inevitable process in vivo. 
Cardiovascular diseases such as preeclampsia and atherosclerosis are induced by this 
process, and the end-products of this process such as malondialdehyde (MDA) and 4-
hydroxynonenal (HNE) can cause damage to proteins and to DNA. Lipid peroxidation 
causes damage to biological membrane functions, e.g. it decreases fluidity, inactivates 
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membrane-bound enzymes and receptors, and may alter nonspecific calcium ion 
permeability (Orrenius, 1989; and Bast, 1993).  
Lipid peroxidation induced by oxygen free radicals is believed to play an 
important part in the destruction and impairment of cell membranes, because this 
process degrades polyunsaturated fatty acids (PUFA) in the latter, with consequent 
disruption of membrane integrity (Tappel, 1973). 
Previous studies have reported that lipid peroxidation plays a significant role in 
the pathogenesis of gastric mucosal lesions induced by water immersion restraint stress, 
burn shock, and ischemia-reperfusion (Yoshikawa et al., 1986, 1987, 1989). 
 
2.7 Heat shock proteins 
Heat shock response was first reported by Ritossa (1962), who observed it in 
Drosophila melanogaster chromosomes after subjecting these flies to heat treatment. A 
heat shock response then increases the expression of genes encoding a special class of 
proteins, called heat shock proteins (HSPs) or stress proteins. 
Heat shock proteins play important roles in both normal conditions and 
pathological situations involving either systemic or cellular stress. Previous studies have 
shown that most HSPs have strong cytoprotective effects, are involved in many 
regulatory pathways, and act as molecular chaperones to preserve important cellular 
proteins (Hightower, 1991, and Arya, 2007). HSPs are essential for the maintenance of 
gastric mucosal cell integrity both during normal cell growth and in several 
pathophysiological conditions (Robert et al., 1983; Lichtenberger, 1999; and Laine et 
al., 2008). 
Heat shock proteins are also implicated in gastric cytoprotection. HSPs are a 
group of highly conserved proteins that are induced in response to heat and other 
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stresses (Kinouchi et al., 1994; and Schiaffonati & Tiberio, 1997). They are classified 
into subfamilies according to their molecular weight, such as small HSPs (16–30 kDa), 
HSP40, the predominantly mitochondrial HSP, HSP60, HSP70, HSP90 and the large 
HSP110. 70 kDa heat shock proteins assist in both the assembly and transport of newly 
synthesized proteins within cells and also the removal of denatured proteins. Therefore, 
HSP70 plays a role in preventing damage and in cellular repair processes after injury. 
Previous studies have also found the induction of HSP70 in response to heat, ethanol, 
oxidative stress, or water immersion–restraint stress in the gastric mucosal cell (Zeniya 
et al., 1995; and Hirakawa et al., 1996). However, only a few studies have reported 
locating HSP70 in the injured stomach. 
 
2.7.1 Heat shock proteins and the stomach  
 
The stomach is one of the organs in our body that is often exposed to outside 
irritants such as hot food, alcohol, and oxidants generated from ingested food and H. 
pylori-associated infection. Alcohol is one of major factors that cause gastric mucosal 
injuries including gastritis or ulcers. 
Some studies showed that HSPs contribute to adaptive cytoprotection in the 
gastrointestinal mucosa. Among the HSPs, HSP70 is believed to be the one that plays 
an important role in the defense mechanism of gastrointestinal mucosa. HSPs are 
reported to have been induced both in in vitro and in vivo. According to Nakamura et al. 
(1991), HSPs were induced by heat shock treatment resistant 7.5% ethanol in cultured 
guinea pig gastric mucosal cells. In an in vivo study, it was reported that an 
overexpression of HSPs was induced by water-immersion restraint (WIR) stress in 
animals pretreated with hyperthermia, as compared with stress alone (Itoh & Noguchi, 
2000). Hirakawa et al. (1996) revealed that the oral administration of the anti-ulcer drug 
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geranylgeranylacetone (GGA) produced HSP60, HSP70, HSC70, and HSP90 in the 
gastric mucosa of normal rats. Park et al. (2008) also demonstrated that HSP70 
inductions protected rats against ethanol-induced gastric mucosal damages. 
These results suggest that HSPs, especially HSP70, induce resistance in the 
gastric mucosa against stress-induced mucosal damage. HSPs thus play a protective role 
in gastric mucosa under stressful conditions.  
 
2.7.2 Heat shock proteins and protection against oxidative stress 
 
Heat shock proteins also play an important role in other cellular processes that 
occur during and after exposure to oxidative stress. Oxidative stress occurs as a result of 
an imbalance between the productions of reactive oxygen species (ROS) and the 
detoxifying process of reactive intermediates. As a consequence, this imbalance 
generates excessive ROS, which leads to the oxidation and aggregation of vital proteins 
and of DNA, causing a failure of normal cell functions.  
Under such stress conditions, some HSPs, especially the HSP70 family and its 
co-chaperones, are synthesized at high levels. Members of the HSP70 protein family 
include: HSC70 (a constitutive HSP70), present within the cytoplasm and nucleus; 
grp75, a mitochondrial HSP70; and grp78 (Bip), a resident of the endoplasmic 
reticulum. 
The HSP70 protein family functions as molecular chaperones in refolding 
denatured polypeptide (Gething & Sambrook, 1992; Hendrick & Hartl, 1993; Becker & 
Craig, 1994; and Hartl, 1996). A molecular chaperone is defined as a protein that binds 
to newly synthesized proteins and refolds denatured proteins (Bukau & Horwich, 1998; 
and Young et al., 2004). 
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Members of the HSP70 family and its co-chaperones select and direct abnormal 
proteins to the proteasome or lysosomes for degradation (Mayer & Bukau, 2005). 
Previous studies have revealed that an overproduction of HSP70 can reduce stress-
induced denaturation as well as the aggregation of certain proteins (Kampinga et al., 
1995; and Kabakov & Gabai, 1995) - further evidence that HSP70 plays an important 
role in protection against stresses (Georgopoulos & Welch, 1993; and Kampinga, 1993). 
Heat shock proteins may also exhibit its protective effects against oxygen radical-
induced cellular damage such as membranes (lipid peroxidation), proteins, DNA, and 
mitochondria. Jacquier-Sarlin et al. (1994) reported the protective effects of HSP70 
against lipid peroxidation and DNA damage. The over-expression of HSPs may 
therefore protect multiple cellular compartments and prevent protein damage from 
oxidative stress. 
 
2.8 Bax protein 
 
The balance between apoptosis and cellular proliferation is a main factor in 
gastric injury and repair. These processes are regulated by several genes, including p53 
and members of the Bcl-2 family such as Bax and Bcl-2 (Haunstetter & Izumo, 1998; 
Boucher et al., 2000; and Rezvani et al., 2000). 
The Bax gene is a proliferative suppressor gene that encodes the Bax protein 
which promotes apoptosis. Bax is a protein that forms an isomeric dimmer with Bcl-2. 
It counteracts the action of Bcl-2 in the presence of various cell death signals, and 
induces apoptosis (Wu et al., 1998). Bax protein expression has been identified in 
various human tissues such as the prostate, colon, breast, testis and ovary. However, 
little is known about Bax protein expression in gastric injury. Qiao et al. (2011) 
reported high levels of expression of Bax protein in the early stages of the gastric 
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ischemia reperfusion of rats, which decreased gradually after that. This suggests that a 
down-regulation of Bax protein is related to healing effects in gastric ulcers. 
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3.0 Materials and methods 
3.1 Mushroom and preparation of mushroom extracts 
One batch of 20kg fresh basidiocarp of H. erinaceus KUM 61131 was collected 
from Highland & Lowland Mushroom Industry, Selangor, Malaysia. Fresh H. erinaceus 
fruit bodies were sliced and frozen at -20 ± 2 °C prior to freeze-drying at -50 ± 2 °C.  
The extraction was based on the method by Wong et al. (2007). Freeze-dried 
fruit bodies of H. erinaceus were blended into powder. The yield was 13.57%. The 
powdered fruit bodies were soaked with distilled water at a ratio 1:10 (w/v) and left for 
24 h at 27 ± 2°C. The soaked fruit bodies were then boiled for 30 min with agitation, 
left covered for 30 minutes, and filtered cold using Whatman no.1 filter paper. The 
extract was then freeze-dried. The yield was 27.47%. 
 
3.2 The toxic effects, if any, of extracts freeze-dried fruit bodies of H. erinaceus to 
rats 
 
3.2.1 Animals  
Healthy male and female Sprague Dawley rats weighing between 150 g and 300 
g were used in this study. The female animals used were nulliparous and non-pregnant. 
The animals were fed with pellet feed. Food and water were provided ad libitum during 
acclimation and throughout the study. The animals were maintained under control 
condition of temperature at 26⁰C (±2⁰C) and relative humidity around 44–56%. 
Animals were housed in polypropylene cages over husk beddings and 12 h light and 12 
h dark cycle was maintained throughout the experimental period. All the animal 
experiments were performed after getting necessary approval from the Institutional 
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Animal Ethical Committee (which follows the guidelines of Animal Care and Use 
Committee), Laboratory Animal Science Centre, Faculty of Medicine, University of 
Malaya (Ethics no. ISB/11/08/2010/WJY (R). All efforts were made to minimize both 
the number of animals used and unwanted stress or discomfort to the animals 
throughout the experimental procedures.  
 
3.2.2 Acute toxicity studies 
The acute toxic study was used to determine a safe dose of the mushroom 
extract. Animals were divided into three groups, each group containing six animals. 
Group 1 animals served as control which received distilled water. Group 2 and Group 3 
animals received freeze-dried H. erinaceus powder in single doses of 2 and 5g/kg b/w., 
respectively. The H. erinaceus powder was suspended in sterile distilled water and 
administered by gavage (P.O.). Food was withheld for a further three to four hours after 
treatment (OECD, 2001). The animals were observed for 30 min and 2, 4, 24 and 48 h 
for the onset of clinical or toxicological symptoms. Mortality, if any was observed over 
a period of two weeks. During this period, body weight was recorded weekly to 
evaluate possible toxic effect. After an overnight fast, the animals were sacrificed on the 
15
th
 day. Hematological, serum biochemical and histological (liver and kidney) 
parameters were determined using standard methods. The experimental flow is given in 
Figure 3.1. 
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Acute toxicity test 
 
 
 
2 weeks observation if no mortality 
 
 
Sacrificed on 15
th
 day 
 
 
Figure 3.1: Flow diagram of the acute toxicity studies. 
3.3 The gastroprotective effects of H. erinaceus extract in rats 
The rats were starved for 24 hours (Garg et al., 1993) but had free access to 
drinking water until two hours before the experiment. On the day of experiment, the rats 
were randomly divided into seven groups with six animals. Each group received oral 
dose of distilled water (ulcer-free control group), distilled water (ulcer control group), 
four different concentrations of mushroom extracts (50, 100, 200, and 400mg/kg b/w., 
respectively) in distilled water and Omeprazole in distilled water (positive control group) 
were the treatments to investigate gastroprotective activities, if any, of aqueous extracts 
of H. erinaceus (Figure 3.2). All groups were orally fed with 95% alcohol (De Pasquale 
et al., 1995) one hour after their pre-treatment, except ulcer-free control group which 
Low dose (2g/kg) 
 
High dose (5g/kg) 
Blood test (biochemical parameters test) Histological lesions evaluation in 
liver and kidney 
Control group 
(Distilled water) 
Fast rats overnight 
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was given distilled water, 5ml/kg. The animals were under mild ether anaesthesia. The 
pyloric portion of stomach was identified, slightly lifted out and ligated, avoiding 
traction to the pylorus or damage to the blood supply. The stomach was then replaced 
carefully and abdominal wall was closed by interrupted sutures. Four hours after 
ligation, all animals were sacrificed. The stomach was cut along the greater curvature 
and separated from the surrounding tissues and thus brought out as a whole along with 
its contents. The content (gastric juice) was subjected to centrifugation at 3000 rpm for 
10 min and the pellate was then analysed for mucous content. Tissues were 
homogenized with phosphate buffer saline (PBS). Both serum and tissue homogenates 
were stored at -80°C until further analysis. 
      
 
 
 
 
 
 
                                                  
                     Figure 3.2: Flow diagram of the gastricprotective studies (Abdulla et al., 2008). 
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3.4 The ulcer healing effects of H. erinaceus extract in rats 
The ulcer healing activity of H. erinaceus was performed in ethanol induced 
ulcer model (Figure 3.3). In this test, the two concentrations of the mushroom extracts 
that showed best results were used in ulcer treatment tests. The rats were starved for 24 
hours (Mohamad Omar et al., 2011) but had free access to water until two hours before 
the experimentation. The rats were randomly divided into five groups: control group (no 
treatment), positive group (treated with Omeprazole), negative group (treated with 
distilled water), low dose group (200mg/kg) and high dose group (400mg/kg). Each 
groups contained six animals. On the first experiment day, the control group was 
sacrificed without any treatment. The remaining groups were provided with food and 
water prior to the experiment day and this was followed by the respective treatments for 
three days. All animals were anaesthetised with ketamine and sacrificed; stomachs were 
collected for histological analysis (Wasman et al., 2010). 
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Figure 3.3: Flow chart for ulcer treatment tests (Mohamad Omar et al., 2011). 
 
3.5 Gross gastric lesions evaluation 
Ulcers were found in the gastric mucosa, appearing as elongated bands of 
hemorrhagic lesions parallel to the long axis of the stomach. Each gastric mucosa was 
examined for damage. The length (mm) and width (mm) of ulcer on gastric mucosa 
normal control 
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were measured by a planimeter (10 × 10 mm
2
 = ulcer area) under dissecting microscope 
(x1.8). 
The area of each ulcer lesion was measured by counting the number of small 
squares, 2 × 2 mm, covering the length and width of each ulcer band. The sum of the 
areas of all lesions for each stomach was applied in the calculation of the ulcer area (UA) 
wherein the sum of small squares × 4 × 1.8 = UA mm
2
 as described by Kauffman and 
Grossman (1978) with slight modification. The inhibition percentage (I %) was 
calculated by the following formula as described by Njar et al. (1995) with slight 
modification. 
(I %) = [(UAcontrol − UAtreated) ÷ UAcontrol] × 100%. 
3.6 Measurement of mucus production 
Gastric mucus production in the rats that were subjected to ethanol-induced 
gastric mucosal injury was measured. The gastric mucosa of each rat was gently scraped 
using a glass slide and the mucus obtained was weighed using a precision electronic 
balance (Tan et al., 2002). 
3.7 Gastric wall mucus determination 
The modified method of Corne et al. (1974) was used to determine gastric wall 
mucus. The glandular segments from stomach, which had been opened along their 
greater curvature, were weighed. All weighed segments were transferred immediately to 
10 ml of 0.1%, w/v alcian blue solution (in 0.16 M sucrose solution, buffered with 0.05 
M sodium acetate adjusted to pH 5.8 with HCl). Segments were stained for two hours, 
excess dye was removed by two successive rinses with 10 ml of 0.25 M sucrose, first 
for 15 min and then for 45 min. Alcian blue complexed with the gastric wall mucus was 
extracted with 10 ml of 0.5 M magnesium chloride, by shaking for one min at 30 min 
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intervals for two hours. The resulting blue solution was shaken vigorously with an equal 
volume of diethyl ether and then the emulsion was centrifuged at 3000 rpm for 10 min 
and the absorbance of the aqueous layer against blank standard MgCl2 solution was 
recorded at 580 nm. The quantity of alcian blue recovered from per gram of net 
glandular tissue was then calculated. 
3.8 Histological evaluation of gastric lesions 
Specimens of the gastric walls from each rat were fixed in 10% buffered 
formalin and processed in a paraffin tissue processing machine. Sections of the stomach 
were made at a thickness of 5μm and stained with hematoxylin and eosin for 
histological evaluation.  
Histological analyses were made using a Nikon microscope with NIS-Elements 
D Imaging Software 2.30 version. The images were manipulated in ACDSee Version 
10.0 Photo Manager to enhance the image resolution and to frame the plates. 
3.9 Immunohistochemistry  
Tissue section slides were heated at 60
°
C for approximately 25 min in hot air 
oven (Venticell, MMM, Einrichtungen, Germany). The tissue sections were 
deparaffinized in xylene and rehydrated using graded alcohol. Antigen retrieval process 
was done in 10mM sodium citrate buffer boiled in microwave. Immunohistochemical 
staining was performed according to manufacturer’s protocol (Dakocytomation, USA). 
At first, endogenous peroxidase was blocked by peroxidase block (0.03% hydrogen 
peroxide containing sodium azide) for five min. Tissue sections were washed gently 
with wash buffer, and then incubated with HSP70 (1 : 500) and Bax (1 : 200) 
biotinylated primary antibodies for 15 min. The sections were rinsed gently with wash 
buffer and placed in buffer bath. The slides were then placed in a humidified chamber 
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and sufficient amount of streptavidin-HRP (streptavidin conjugated to horseradish 
peroxidase in PBS containing an antimicrobial agent) was added and incubated for 15 
min. After that, tissue sections were rinsed gently in wash buffer and placed in buffer 
bath. Diaminobenzidined (DAB-) substratechromagen was added to the tissue sections 
and incubated further for five min following washing and counterstaining with 
hematoxylin for five second. The sections were then dipped in weak ammonia (0.037 
mol/L) 10 times, then rinsed with distilled water and covered with cover slip. Positive 
findings of the immunohistochemical staining should be seen as brown stains under 
light microscope. 
 
3.10 Estimation of free radical generation 
 
3.10.1 Lipid peroxidase (LPO) 
The LPO assay was assessed based on a method described by Maelinda et al. 
(2008) but with minor modifications. 0.25 ml of tissue homogenated was mixed with 
same amount of freshly prepared 15% TCA. The mixture was centrifuged at 3500 rpm 
for five minutes. 0.4 ml of supernatant was taken out and mixed with 0.5 ml of 1% TBA. 
The reaction tubes were kept in a boiling water bath for 30 minutes. Upon cooling, the 
tubes were centrifuged at 3500 rpm for five minutes to remove precipitated protein. The 
formation of TBARS was measured by removing 200 µl of supernatant and measuring 
the absorbance at 532 nm. Each assay was carried out in triplicate. The results are 
expressed as µM 1,1,3,3-tetraetoxypropane equivalent. 
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3.10.2 Superoxide dismutase (SOD) activity 
Superoxide dismutase (SOD) was determined by using Superoxide Dismutase 
Assay Kit (Catalog no. 706002, from Cayman Chemical Company, Ann Arbor, MI 
48108). Figure 3.4 shows the process: 
  
 
 
 
 
 
 
Figure 3.4: Superoxide dismutase (SOD) assay (SOD assay kit, Cayman Chemical Company). 
 
3.10.3 Catalase (CAT) activity 
Catalase (CAT) was investigated by using Catalase Assay Kit (Catalog no. 
707002, from Cayman Chemical Company, Ann Arbor, MI 48108). The method was 
based on the reaction of the enzyme with methanol in the presence of an optimal 
concentration of H2O2. The formaldehyde produced was measured colorimetrically with 
4-amino-3-hydrazino-5-mercapto-1,2,4-triazole (Purpald) as the chromogen by using 
plate reader at a wavelength of 540nm. The process involved in the assay is shown 
below (Figure 3.5): 
 
200 µl of the diluted Radical Detector and 10 µl of samples were added to the wells. 
Reaction was initiated by adding 20 µl of diluted Xanthine Oxidase to the wells. 
The 96-well plate was carefully shaked for a few seconds to mix. 
The plate was incubated on a shaker for 20 minutes at room temperature. 
Read absorbance at 440 nm using a plate reader. 
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Figure 3.5: Catalase Assay (Catalase assay kit, Cayman Chemical Company). 
3.11 Statistical analysis 
All values were reported as mean ± S.E.M. Statistical analysis done using SPSS 
version 17.0. The significance of differences amongst groups was assessed using one-
way ANOVA and Tukey multiple range test. A value of p < 0.05 was considered as 
statistically significant. 
 
 
100 µl of diluted Assay Buffer, 30 µl of methanol, and 20 µl of sample were 
added to wells. 
20 µl of diluted Hydrogen Peroxide was added to all the wells to initiate the 
reactions. 
The plate was covered with plate cover and incubated on a shaker for 
20 minutes at room temperature. 
30 µl of diluted Potassium Hydroxide was added to each well to terminate the 
reaction and then 30 µl of Catalase Purpald (Chromagen) was added to each 
well. 
The plate was covered with plate cover and incubated for 10 minutes at 
room temperature on a shaker. 
 
10 µl of Catalase Potassium Periodate was added to each well. The plate 
was covered with plate cover and incubated for five minutes at room 
temperature on a shaker. 
 
 
Read absorbance at 540 nm using a plate reader. 
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4.0 Results and Discussion 
4.1 Acute oral toxicity studies on aqueous extracts of H. erinaceus 
Animals treated with H. erinaceus extract at a doses of 2 and 5 g/kg were kept 
under observation for 14 days. Both sexes of rats showed no signs of toxicological 
effects during the experimental period after a single oral dose administration of the 
extract at 2 or 5 g/kg when compared to control group. Further, there was no mortality 
for rats administered with the extracts. In current study, all animals did not show any 
abnormal behavioural expressions and toxicological signs during experimental period. 
 
4.1.1 Body weight of experimental rats 
Evaluation of toxicity was carried out by observing body weight changes of the 
animals as shown in Figure 4.1 and Figure 4.2. During the two weeks period, body 
weight of male and female rats increased gradually from 0 day to 14 days in the three 
groups. Further, body weight of rats that received low or high dosage of H. erinaceus 
extract did not reveal significant differences when compared to animals in control group. 
The increases in body weight in male and female rats indicated that nutritional state of 
the animal was not compromised by the extracts. The results showed similarity to that 
obtained by Watthanachaiyingcharoen et al. (2009). However, it was not similar to the 
findings by Adebajo et al. (2006). Watthanachaiyingcharoen et al. (2009) showed that 
the body weight of both sexes’ rats that received medicinal plant powder showed 
increase during the 14 days of observation period. However, Adebajo et al. (2006) 
found that rats that fed with Murraya koenigii leaf methanol extract at doses (250-
450mg/kg) showed reduction in body weight and hepatic injury was observed after two 
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weeks experiment. This reduction in the body weight may be an indicator to evaluate 
the toxicity of selected natural compounds or extracts.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1: The effects of the aqueous extract of H. erinaceus on weight in the control and treated male 
rats during 14 days in the acute toxicity study. Means with same letters were not significantly different 
(p < 0.05) by Tukey Test. Six replicates animals were used for each treatment. 
Figure 4.2: The effects of the aqueous extract of H. erinaceus on weight in the control and treated 
female rats during 14 days in the acute toxicity study. Means with same letters were not significantly 
different (p < 0.05) by Tukey Test. Six replicates animals were used for each treatment. 
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4.1.2 Histopathological examination of livers and kidneys of rats 
No signs of morphological injury or lesion were found in the liver of rats treated 
with low and high doses of extracts. Normal cellular architecture with binucleated 
formation around the central veins was observed and the hepatocytes were arranged in 
cords (Plate 4.1a-c). These results showed that the H. erinaceus extract did not alter the 
physiological activities of the liver. 
 
 
 
 
 
 
   
 
  
  
   
   
Plate. 4.1: Histological sections of liver in acute toxicity test. (a) Rats treated with 5 ml/kg  
vehicle (distilled water), (b) Rats treated with 2 g/kg (5 ml/kg) H. erinaceus extract,  
(c) Rats treated with 5 g/kg (5 ml/kg) H. erinaceus extract. (Haematoxylin and Eosin  
staining, 20x). Note the hepatocytes were arranged in cords (arrows). 
 
The kidney of rats that were oral-administered with low and high doses of 
extracts showed normal glomeruli with normal vascularity. The collecting tubules were 
similar to that of control groups (Plate 4.2 a-c). The epithelial linings of both proximal 
and distal tubules were of normal architecture. No signs of morphological injury or 
b a 
c 
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lesion were found in the kidney. These results indicated that the H. erinaceus extract did 
not have toxic effects on the physiological activities of the kidney.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Plate 4.2: Histological sections of kidney in acute toxicity test. (a) Rats treated with 5 ml/kg  
vehicle (distilled water), (b) Rats treated with 2 g/kg (5 ml/kg) H. erinaceus extract,  
(c) Rats treated with 5 g/kg (5 ml/kg) H. erinaceus extract. (Haematoxylin and Eosin  
staining, 20x). Note the normal glomeruli (arrows). 
 
 
4.1.3 Hematological and clinical biochemistry 
 
The effects of aqueous extracts of H. erinaceus on haematological parameters of 
treated and control rats are presented in Table 4.1. The hematological status of rats after 
14 days of oral-administration of H. erinaceus extract was not significantly (p < 0.05) 
different when compared to the control group rats. Both animals and humans have 
similar toxicity patterns in haematological, gastrointestinal and cardiovascular adverse 
a b 
c 
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effects (Oslon et al., 2000). Hematological parameters in animals are important markers 
to reveal the risk of toxic as the changes in the blood system have a higher predictive 
value for human toxicity. In this study, Table 4.1 shows that both sexes of rats had 
increased level of Erythrocyte (RBC) in extracts group when compared to control group, 
though there were no significant (p < 0.05) difference between the three groups. The 
leukocyte (WBC) level in female high dose rats, 5.45 ± 0.56 (10^9/L) was higher than 
in control group 4.47 ± 0.55 (10^9/L), though no significant difference were found 
between groups.  Further, in female rats, there was an increase trend for platelet 
parameter in extracts group when compared to control group. Platelet level was 691.00 
± 56.42 (10^9/L) in low dose group and 745.50 ± 33.35 (10^9/L) in high dose group. 
Both groups showed higher level than rats in control group (640.33 ± 43.64 (10^9/L)). 
However, there were no significant (p < 0.05) difference between the three groups. 
Erythrocyte (RBC), leukocyte (WBC), or thrombocytes (platelet) are blood cells formed 
during hematopoiesis process. Increased production in RBC, WBC and platelet 
indicated that there was a stimulation of the hematopoiesis system (Guyton & Hall, 
2006). Erythrocyte plays role in boosting the immune system, WBC defend our body 
from being attack by foreign organisms and the platelets protect blood vessels from 
endothelial damage as well as initiate repair of these vessels. Thus, this suggests that H. 
erinaceus extract may have strong immuno-modulatory, antioxidant and endothelial 
protection and repair activity. As shown in Table 4.1, there were no significant changes 
(p < 0.05) in MCV, MCH, MCHC and RDW. Moreno Chulilla et al. (2009) stated that 
these parameters are major indices for the basis of morphological anaemia classification. 
In the present study, the extract did not significantly change the calculated RBC indices 
and had minimal effect on the size of RBC and in Hb content per RBC. This shows that 
H. erinaceus extracts may not have the potential to induce anaemia. 
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HGB: Hemoglolin;  
HCT: Hematocrit;  
RBC: Red Blood Cell (eErythrocyte); 
MCV: Mean Corpuscular Volume; 
MCH: Mean Corpuscular Hemoglolin; 
MCHC: Mean Corpuscular Hemoglolin;  
RDW: Red Blood Cell Distribution Width; 
WBC: White Blood Cell (leukocyte) 
 
 
 
 
 Control group Low dose group High dose group 
Male Female Male Female Male Female 
HGB (g/L) 147.33 ± 3.12 141.00 ± 3.40 150.67 ± 2.89 132.00 ± 9.01 145.00 ± 2.50 144.17 ± 1.90 
HCT 
(L/L) 
0.48 ± 0.01 0.46 ± 0.01 0.49 ± 0.01 0.46 ± 0.01 0.48 ± 0.01 0.48 ± 0.01 
RBC 
(10^12/L) 
8.18 ± 0.13 7.80 ± 0.24 8.40 ± 0.24 7.84 ± 0.21 8.39 ± 0.14 7.98 ± 0.16 
MCV  
(fl) 
58.50 ± 1.38 59.50 ± 1.06 58.00 ± 1.03 58.50 ± 0.76 56.83 ± 0.31 59.67 ± 0.95 
MCH 
(pg) 
18.03 ± 0.37 18.08 ± 0.25 18.00 ± 0.29 16.78 ± 0.92 17.27 ± 0.13 18.08 ± 0.23 
MCHC 
(g/L) 
308.50 ± 2.57 304.83 ± 3.20 310.17 ± 0.70 287.83 ± 16.21 304.17 ± 1.54 304.00 ± 1.79 
RDW 
(%) 
15.70 ± 0.58 15.05 ± 0.49 14.77 ± 0.45 13.85 ± 0.25 16.02 ± 0.46 14.00 ± 0.28 
WBC 
(10^9/L) 
6.32 ± 0.72 4.47 ± 0.55 7.48 ± 0.44 4.42 ± 0.50 6.28 ± 0.47 5.45 ± 0.56 
Platelet 
(10^9/L) 
759.33 ± 27.88 640.33 ± 43.64 738.00 ± 50.79 691.00 ± 56.42 756.67 ± 30.26 745.50 ± 33.35 
Table 4.1: Hematological parameters of the male and female rats treated with distilled water and H. erinaceus aqueous extract during the acute toxicity study. 
 
All values were expressed as mean and ± standard error mean. No significant differences in treated rats when compared with 
control rats. 
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The biochemical analyses were assessed in both female and male rats and 
summarised in the Table 4.2 and 4.3. In renal function tests, there were no significant 
differences between treated female rats and control rats. Further, renal profiles of male 
rats were not significantly different when compared to the control except for potassium 
level. Potassium level was significantly (p < 0.05) elevated when compared to the rats 
in control group (4.77 ± 0.06 mmol/L). In the low dose group, the level was 5.08 ± 0.08 
mmol/L whereas in the high dose group the level was 5.08 ± 0.09 mmol/L, and there was 
no significant difference (p < 0.05) between the two groups (Table 4.2).  
 
Normal renal function is related to normal concentration of potassium in serum 
because more than 80% of the ingested potassium is excreted in the urine (Van Y 
Persele De Strihou, 1977). Serum potassium level which showed slightly above normal 
limits is a progressive sign of renal failure. However, normal architecture that was 
observed in kidney (Plate 4.2 b and c) showed that H. erinaceus extracts did not affect 
the kidney function when compared to normal group rats. 
 
The observation of differences in renal function could be linked with the chronic 
progressive nephropathy that may affect the Sprague-Dawley rats. Kohn and Clifford 
(2002) reported that this age-related disease is more frequent in male rats. Stock animal 
variations, however, may be the main factor that caused the differences in elevated 
potassium levels in both groups of rats treated with low and high doses of extract. 
 
From the renal function profile result, creatinine and urea levels in extracts 
group was not significantly different (p < 0.05) when compared to the control rats. 
Creatinine and urea are two important markers of kidney function (Arneson & Brickell, 
2007). The insignificant changes in creatinine and urea levels implied that the activity of 
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protein metabolism was maintained within the normal range due to the non-toxic effect 
of the extract. 
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All values were expressed as mean and ± standard error mean. Means with different superscripts were significantly different (p < 0.05) by Tukey Test. Six replicates of animals were 
used in each group. 
 
 
 
 Control group Low dose group High dose group 
Male Female Male Female Male Female 
Sodium (mmol/L)  
142.00 ± 0.58 141.83 ± 0.40 142.00 ± 0.52 141.00 ± 0.68 142.50 ± 0.34 141.17 ± 0.48 
Potassium (mmol/L) 
4.77 ± 0.06
a
 
4.62 ± 0.12 
5.08 ± 0.08
b
 
4.57 ± 0.16 
5.08 ± 0.09
b
 
4.53 ± 0.08 
Chloride (mmol/L) 104.00 ± 0.82 105.33 ± 0.67 106.33 ± 1.02 105.33 ± 0.67 105.17 ± 0.54 106.00 ± 0.63 
Carbon Dioxide 
(mmol/L) 
24.82 ± 0.54 23.33 ± 0.41 22.60 ± 1.18 22.95 ± 0.41 23.92 ± 1.03 21.95 ± 0.77 
Anion Gap (mmol/L) 18.17 ± 0.48 18.00 ± 0.26 18.17 ± 0.60 17.33 ± 0.49 18.50 ± 0.43 17.67 ± 0.49 
Urea (mmol/L) 5.20 ± 0.35 7.93 ± 0.31 6.20 ± 0.50 7.97 ± 0.19 5.63 ± 0.18 8.30 ± 0.67 
Creatinine (μmol/L) 34.83 ± 2.27 41.00 ± 2.79 33.67 ± 2.69 42.00 ± 4.76 34.33 ± 4.96 41.33 ± 2.12 
Table 4.2: Renal function parameters of the male and female rats treated with distilled water and H. erinaceus aqueous extract during the acute toxicity study. 
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For the evaluation of liver function, as shown in Table 4.3, male rats showed 
significant difference (p < 0.05) in alanine aminotransferase (ALT). Control group had 
the highest ALT value (51.83 ± 1.92 IU/L) when compared to low dose group (48.00 ± 
0.58 IU/L) and high dose group (46.50 ± 1.45 IU/L) whereas in female rats, there was 
significant difference (p < 0.05) in alkaline phosphatase (ALP) compared control group 
(114.83±10.10 IU/L) and low dose group (72.83 ± 5.16 IU/L) (Table 4.3). From the 
result, male rats treated with low dose extract had higher ALP level (163.17 ± 15.40 
IU/L) than control group (153.00 ± 15.14 IU/L), followed by high dose group (135.00 ± 
9.04 IU/L). However, there was no significant difference (p < 0.05) between the three 
groups. The variation of liver linked enzymatic activity could be associated of age, sex 
and other factors (i.e. diets) (Braun et al., 1993). However, the ALP variation is well 
related to the (6-8 weeks) age of animals and especially with the higher bone 
metabolism in younger ones.  
Table 4.3 shows that both sexes of rats showed increased trend in AST level in 
H. erinaceus extract groups when compared to control group. However, there was no 
significant difference (p < 0.05) between the groups. Both sexes of rats had the lowest 
AST level in control group. In male rats, low dose group had the highest AST level 
(181.83 ± 5.48 IU/L), followed by high dose group (175.83 ± 8.51 IU/L). Female rats in 
low dose group had 172.17 ± 10.35 IU/L, whereby the level of AST in high dose group 
increased by 10 IU/L, which is 182.83 ± 5.61 IU/L. 
 As shown in Table 4.3, male control rats had same G-Glutamyl Transferase 
level with male rats treated with high dose of extract (3.17 ± 0.17 IU/L), and both 
groups showed lower level than low dose groups (3.67 ± 0.42 IU/L). However, all three 
groups showed no significant difference (p < 0.05). In contrast to male group, female 
control group had the highest G-Glutamyl Transferase level (3.67 ± 0.33 IU/L), 
followed by low dose group (3.50 ± 0.50 IU/L) and high dose group (3.00 ± 0.00 IU/L). 
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Both groups did not show significant difference though there were changes in the 
groups.   
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All values were expressed as mean and ± standard error mean. Means with different superscripts were significantly different (p < 0.05) by Tukey Test. Six replicates of animals were 
used in each group. 
 
 Control group Low dose group High dose group 
Male Female  Male Female Male Female 
Total Protein (g/L) 61.33 ± 1.15 64.33 ± 1.26 57.83 ± 0.65 63.33 ± 1.17 60.17 ± 1.01 65.00 ± 0.68 
Albumin (g/L) 9.83 ± 0.48 11.17 ± 0.17 8.67 ± 0.33 11.00 ± 0.45 9.83 ± 0.48 11.50 ± 0.43 
Globulin (g/L) 51.50 ± 1.09 53.17 ± 1.28 49.17 ± 0.60 52.33 ± 1.26 50.33 ± 1.09 53.50 ± 0.72 
Total Bilirubin (μmol/L) 2.17 ± 0.17 2.00 ± 0.00 2.00 ± 0.00 2.00 ± 0.00 2.00 ± 0.00 2.00 ± 0.00 
Conjugated Bilirubin (μmol/L) 1.00 ± 0.00 1.00 ± 0.00 1.00 ± 0.00 1.00 ± 0.00 1.00 ± 0.00 1.00 ± 0.00 
Alkaline Phosphatase (IU/L) 153.00 ± 15.14 114.83 ± 10.10
b
 163.17 ± 15.40 72.83 ± 5.16
a
 135.00 ± 9.04 94.00 ± 7.15
ab
 
Alanine Aminotransferase (IU/L) 51.83 ± 1.92
b
 43.17 ± 1.94 48.00 ± 0.58
ab
 39.67 ± 2.70 46.50 ± 1.45
a
 44.50 ± 1.88 
AST (IU/L) 171.50 ± 7.13 171.33 ± 6.84 181.83 ± 5.48 172.17 ± 10.35 175.83 ± 8.51 182.83 ± 5.61 
G-Glutamyl Transferase (IU/L) 3.17 ± 0.17 3.67 ± 0.33 3.67 ± 0.42 3.50 ± 0.50 3.17 ± 0.17 3.00 ± 0.00 
Table 4.3: Liver function parameters of the male and female rats treated with distilled water and H. erinaceus aqueous extract during the acute toxicity study. 
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Among the biochemical parameters tested, AST, ALT and ALP are considered 
as important markers of liver function (Arneson & Brickell, 2007; and Obici et al., 
2008). Rise of AST and ALT level in serum level are indicators for hepatocellular 
damage. Aniagu et al. (2004) stated that ALT enzyme is considered a more sensitive 
marker of hepatocellular damage than AST because ALT is localized in the cytosol of 
hepatocytes and provides a quantitative evaluation of the degree of damage sustained by 
the liver. 
Increase in ALP level is often linked with various disorders such as extra-
hepatic bile obstruction, intra-hepatic cholestasis, infiltrative liver disease, hepatitis and 
bone diseases (Adinortey et al., 2012). However, increase of ALP in less than three 
times the normal level is considered non-specific and will not affect the normal activity 
of liver (Rosalki & Mcintyre, 1999; and Pagana & Pagana, 2003). Mukherjee (2005) 
demonstrated that extremely high ALP level in serum is seen in cases of obstructive 
jaundice and biliary cirrhosis. Both ALP and GGT levels are expected to be high if 
there is bile duct obstruction in liver. Since there were no significant changes (p < 0.05) 
in both ALP and GGT levels, this indicated that normal liver function was observed 
after administration of H. erinaceus extract. This result correlated with findings from 
histopathological examination of the liver, as it showed normal cellular architecture.  
Bilirubin is a major breakdown product of haemoglobin. Therefore, bilirubin 
level in serum is considered an indicator of liver function because it shows that the liver 
possesses ability to take up, process and secrete bilirubin into the bile (Abotsi et al., 
2011). Table 4.3 reveals that both sexes of rats showed no significant difference (p < 
0.05) and change in total bilirubin and conjugated bilirubin between control and extract 
groups. From the results, H. erinaceus extract did not show any adverse effects on 
hepatic metabolism or bililary secretion. 
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Plasma proteins such as total protein, albumin and globulin are produced by 
liver. After 14 days of H. erinaceus extract administration, the level of total protein, 
albumin and globulin in extract treated groups were not significantly different (p < 0.05) 
when compared to the control group. Therefore, administration of H. erinaceus extracts 
did not affect the production of plasma protein in liver. 
In the present study, the H. erinaceus extract did not affect the clinical 
biochemistry parameters and body weight. Further, histological evaluation showed no 
signs of toxicity. Therefore, the extract was considered safe at concentrations tested. 
There were no signs of acute toxicity and the oral lethal dose (LD50) for the male and 
female rats was greater than 5 g/kg body weight. 
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4.2 Gastroprotective effects of H. erinaceus extract in vivo  
 
4.2.1 Effect of H. erinaceus extracts on gross ethanol-induced gastric lesions in rats 
The gastroprotective activity of H. erinaceus extract in ethanol-induced gastric 
lesion model is shown in Plate 4.3 (a-g). It was observed that the gastroprotective effect 
of H. erinaceus extracts on gastric mucosa was in a dose dependent manner (Plate 4.3a-
g). Ethanol produced extensive visible black hemorrhagic lesions of gastric mucosa 
(Plate 4.3b). Results showed that rats that were oral-administered with omeprazole or H. 
erinaceus extracts had significantly (p < 0.05) reduced areas of gastric ulcer formation 
as compared with ulcer control group (Plate 4.3b). In addition, 400 mg/kg of H. 
erinaceus extract significantly (p < 0.05) inhibited the formation of the ulcers. It was 
observed that protection of gastric mucosa was the most significant (p < 0.05) in rats 
pre-treated with 400 mg/kg mushroom extract (Plate 4.3g).  
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Plate 4.3: Gross appearance of the gastric mucosa in rats with ethanol-induced ulcers. (a) Rats pre-treated with 5ml/kg distilled water (normal control).  
No injuries to the gastric mucosa are observed. (b) Rats pre-treated with 5ml/kg distilled water (ulcer control). Severe injuries are observed in the gastric  
mucosa. Ethanol produced extensive visible hemorrhagic necrosis (arrow) of gastric mucosa. (c) Rats pre-treated with omeprazole (20mg/kg). Injuries to the  
gastric mucosa are milder compared to the injuries seen in the ulcer control rats. (d). Rats pre-treated with H. erinaceus extract (50 mg/kg). Moderate injuries  
are seen in the gastric mucosa. The extract inhibits the formation of gastric lesions induced by ethanol. (e). Rats pre-treated with H. erinaceus extract  
(100 mg/kg).Moderate injuries are seen in the gastric mucosa. The extract inhibits the formation of gastric lesions induced by ethanol (f). Rats pre-treated  
with H. erinaceus extract (200 mg/kg). Mild injuries are seen in the gastric mucosa. The extract reduces the formation of gastric lesions induced by ethanol.  
(g) Rats pre-treated with 400 mg/kg of H. erinaceus extract. Very mild injuries (arrow) to the gastric mucosa are seen. 
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4.2.2 Effect of H. erinaceus on ulcer area and ulcer inhibition in gastric glandular 
tissue of rats 
Ulcer in gastric glandular tissue of pre-treatment ulcer control group (distilled 
water) showed severe mucosal injury (Figure 4.3), whereas the rats pre-treated with 
omeprazole (20mg/kg) or H. erinaceus extract (50, 100, 200, and 400mg/kg) showed 
significantly (p < 0.05) decreased area of gastric lesion formation compared to pre-
treatment with ulcer control group. Hericium erinaceus extract significantly prevented 
the formation of ulcer, in a dose-dependant manner. Ulcer control group had the largest 
ulcer area (894.00 ± 36.69 mm
2
), rats that were treated with H. erinaceus extract at a 
dose of 50mg/kg had 727.20 ± 26.88 mm
2
 of ulcer area, followed by 602.40 ± 29.43 
mm
2
 with 100mg/kg of H. erinaceus extract. The inhibition of ulcer was significant (p < 
0.05) when compared to the standard drug group. There was, however, no significant 
difference (p < 0.05) between the highest dosage of extract (240.00 ± 17.31 mm
2
), 
400mg/kg and the standard drug omeprazole group (285.6 mm
2
). Ulcer areas in rats 
treated with 50mg/kg of H. erinaceus extract (727.20 ± 26.88 mm
2
) were three times 
larger than rats treated with 400mg/kg H. erinaceus extract (240.00 ± 17.31 mm
2
). 
Higher doses of extract gave better protection against the formation of the ulcers 
induced by ethanol.  
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Figure 4.3: Effect of H. erinaceus extract on ulcer area in ethanol induced ulcers in rats.  All values were 
expressed as mean of six replicate values. Means with different letters were significantly different  
(p < 0.05) by Tukey Test. Six replicates animals were in each treatment group. 
 
Figure 4.4 showed the ulcer inhibition percentage for seven different groups of 
treatment. As shown in Figure 4.4, inhibition percentage of ulcer of H. erinaceus 
extracts was increased in a dose dependent manner. Pre-treatment with H. erinaceus 
extract (400mg/kg) exhibited the highest inhibition percentage of ulcer area formation, 
at 72.97%, followed by omeprazole (67.45%), 200mg/kg (48.6%), 100mg/kg (32.17%) 
and 50mg/kg (18.14%). Inhibition percentage of ulcer in omeprazole group (67.45%) 
was comparable to 400mg/kg extract group (72.97%). 
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Figure 4.4: Inhibitory (%) effect of H. erinaceus extract on ethanol-induced ulcer in rats. All values were 
expressed as mean of six replicate values. Means with different letters were significantly different (p < 
0.05) by Tukey Test. Six animals were used in each treatment group. 
 
Ethanol-induced gastric ulcer has been widely used for the experimental 
evaluation of anti-ulcer activity. Gastric lesions produced by ethanol administration 
appeared as multiple haemorrhagic red bands of different sizes along the glandular 
stomach. Szabo et al. (1995) suggest that the ethanol damage to the gastrointestinal 
mucosa starts with microvascular injury, namely disruption of the vascular endothelium 
resulting in increased vascular permeability, edema formation and epithelial lifting. 
Ethanol produces necrotic lesions in the gastric mucosa by its direct toxic effect, 
reducing the secretion of bicarbonates and production of mucus (Marhuenda et al., 
1993). Exposure to ethanol increases the extension of cellular damage in a dose-
dependent way (Mutoh et al., 1990). The H. erinaceus extract at a dose of 400 mg/kg 
gave a 72.93% of ulcer inhibition of the gastric mucosa. This indicated that this 
mushroom possessed protective action on the gastric mucosa (Figure 4.4). This result 
also suggested a possible cytoprotective activity, since ethanol acts directly on gastric 
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mucosal cells. It is well known that ethanol induced gastric ulcers are not inhibited by 
anti-secretory agents such as cimetidine. Thus, omeprazole, one of the proton pump 
inhibitors, was being used in current study as a control. 
 
4.2.3 Effect of H. erinaceus on mucus production in gastric glandular tissue of rats 
 
The mucus weight of the stomach was measured in all test groups of rats, the 
mucus content (g) in the positive control group, administered with omeprazole had a 
higher mucus weight of 1.56 ± 0.07 g as compared to all treated rats (Figure 4.5). Rats 
that were orally administered with ethanol had significantly (p < 0.05) lower mucus 
weight (0.79 ± 0.03 g) when compared to rats in positive group. However, there was no 
significant (p < 0.05) difference between groups treated with H. erinaceus extract at 
concentration of 50, 100, and 200 mg/kg (Figure 4.5).  
Rats in non-treated group that were only administered with distilled water had 
significantly (p < 0.05) lower mucus weight (0.43 ± 0.06 g) as compared to animals 
with ulcer induced by ethanol. This suggested that tissue damage in the stomach would 
increase the production of mucus weight. To regain the balance, drugs of plant origin 
were investigated to inhibit the gastric acid secretion or to activate the mucosal defence 
mechanism by increasing mucus production (Borrelli & Izzo, 2000). The results of this 
study have revealed that the H. erinaceus extracts were able to stimulate the increase 
amount of mucus that can protect stomach against the formation of ulcer induced by 
ethanol. 
62 
 
 
Figure 4.5: Effect of H. erinaceus extract on mucus production in rats with ethanol induced ulcers.  
All values were expressed as mean of six replicate values. Means with different letters were  
significantly different (p < 0.05) by Tukey Test. Six animals were in each treatment group. 
 
It was demonstrated that ulceration induced by ethanol is associated with 
diminished protective factors of the mucosa such as prostaglandin and mucus (Konturek 
et al., 2005). In light of this, the gastroprotective activity of H. erinaceus may be 
attributed to the mucosal protective factor as mucus production increased with 
increasing concentration of extracts. Davenport (1968) reported that the mucus of the 
gastric wall is thought to play an important role as a defensive factor against 
gastrointestinal damage. From our results, pre-treatment with H. erinaceus aqueous 
extract significantly (p < 0.05) increased the gastric mucus production (Figure 4.5). This 
showed that H. erinaceus aqueous extract may play role in the preservation of gastric 
mucus secretion. Mucus is a viscous, elastic, adherent and transparent gel comprised of 
95% water and 5% glycoprotein. Glycoprotein present in mucus is an important 
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protective factor for the gastric mucosa because glycoprotein functions as antioxidant, 
reducing damage in the mucosa induced by free radicals (Repetto & Llesuy, 2002). 
 
4.2.4 Effect of H. erinaceus in gastric barrier mucus production in gastric 
glandular tissue of rats with ethanol-induced ulcer 
 
The effect of distilled water (5 ml/kg), omeprazole (20 mg/kg), and different 
dosage of H. erinaceus extracts (50, 100,200, 400 mg/kg) on gastric barrier mucus in 
gastric ulcer rats induced by ethanol are shown in Figure 4.6. The alcian blue binding 
capacity in ulcer control group (3.42 ± 0.13 µg/g) was siginificantly (p < 0.05) lower 
than in the non-treated rats (5.01 ± 0.46 µg/g) and rats pre-treated with omeprazole and 
H. erinaceus extracts. Omeprazole treated group (6.73 ± 0.67 µg/g) had a significant 
lower amount of gastric mucus as compared to H. erinaceus extract groups. It was 
observed that the amount of gastric mucus in rats treated by H. erinaceus extracts 
groups was increased in a dose dependent manner. The binding capacity, however, 
decreased at dosage 400 mg/kg (10.64 ± 0.90 µg/g).  
These results revealed that ethanol inhibited gastric mucus secretion. Similar 
result was reported in García-Barrantes and Badilla (2011). They had demonstrated that 
the binding capacity of alcian blue increased in a dose dependent manner in pylorus-
ligated rats. 
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Figure 4.6: Effect of H. erinaceus extract on gastric barrier mucus in rats with ethanol induced ulcers. All 
values were expressed as mean of six replicate valus. Means with different letters were significantly 
different (p < 0.05) by Tukey Test. Six replicates animals were in each treatment group. 
 
Gastric barrier mucus plays important role in gastroprotection (Kaunitz, 1999). 
Pre-treatment with H. erinaceus aqueous extract significantly (p < 0.05) increased the 
mucoprotective effect. The free mucus was significantly increased as compared to the 
mucus barrier of ulcer control animals (p < 0.05). This mucus comprises of mucin-type 
glycoprotein, which can be detected by a colour dye called alcian blue (Bolton et al., 
1978).  Alcian blue dye is able to bind to negatively charged materials. The mucus gel 
adhering to the gastric mucosal surface protects the underlying epithelium against acid, 
pepsin and necrotizing agents such as ethanol and indomethacin (Alqasoumi et al., 
2008).  In addition, Allen and Flemström (2005) demonstrated that gastric wall mucus 
plays crucial role in the defence of the gastric mucosa against aggression of chemical or 
mechanical factors compared to the soluble mucus in the lumen of the stomach. Gastric 
wall mucus coating may enhance the repair of the damaged gastric epithelium (Shih et 
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al., 2005). Hence, the increase of alcian blue binding capacity to gastric wall mucus 
suggested the involvement of H. erinaceus aqueous extract in process of mucosal 
adaptation by increasing the secretion of mucus in stomach of rats. 
 
4.2.5 Histological evaluation of gastric lesions in stomachs of control and treated 
rats 
Histological observation of ethanol induced gastric lesions in ulcer control group 
pre-treated with sterile distilled water (ulcer control group), showed comparatively 
extensive damage to the gastric mucosa and necrotic lesions penetrate deeply into 
mucosa, and extensive oedema and leucocytes infiltration of the submucosal layer were 
observed (Plate 4.4). Rats that were pre-treated with H. erinaceus extract had 
comparatively better protection of the gastric mucosa as seen by reduction or absence of 
ulcer area, reduced or absence of submucosal edema and leucocytes infiltration (Plate 
4.4). Hericium erinaceus extract has been shown to have the cytoprotective effects in a 
dose-dependent manner. Previous studies that using mushroom extracts in 
gastroprotective did not evaluate on histological test. 
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Plate 4.4: Histological study of ethanol-induced gastric mucosal damage in rats. (a) Rats pre-treated with 5ml/kg distilled water (normal control group). No injuries  
to the gastric mucosa are seen. (b) Rats pre-treated with 5ml/kg ethanol (ulcer control group). There is severe disruption to the surface epithelium and necrotic  
lesions penetrating deeply into mucosa and extensive edema of submucosa layer and leucocytes infiltration is present. (c) Rats pre-treated with omeprazole (20mg/kg).  
Mild disruption of the surface epithelium mucosa is seen. There is edema and leucocytes infiltration of the submucosal layer. (d) Rat pre-treated with H. erinaceus  
extract (50 mg/kg). Moderate disruption of surface epithelium is present. There is leucocytes infiltration in submucosal layer. (e) Rats pre-treated with H. erinaceus  
extract (100 mg/kg). There is mild disruption to the surface epithelium. There is edema with leucocytes infiltration of the submucosal layer. (f). Rats pre-treated  
with H. erinaceus extract (200 mg/kg). There is mild disruption to the surface epithelium. There is edema and leucocytes infiltration of the submucosal layer.  
(g) Rats pre-treated with H. erinaceus extract (400 mg/kg).  There is no disruption to the surface epithelium and no edema or leucocytes infiltration of the submucosal  
layer (H&E stain 10× magnification). Notice leucocytes infiltration in submucosal layer (arrows). 
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Results of the present study showed protection of gastric mucosa and inhibition 
of leucocytes infiltration of gastric wall in rats pre-treated with H. erinaceus extract. 
Cheng and Koo (2000) demonstrated that pre-treatment with plant extract before 
ethanol administration significantly decreased neutrophil infiltration of gastric mucosa. 
While, Shimizu et al. (2000) had shown that the decrease in neutrophil infiltration into 
ulcerated gastric tissue promotes the healing of gastric ulcers in rats. Ethanol damaged 
the gastric mucosa and increased neutrophil infiltration into the gastric mucosa. 
Neutrophils play role in prevention of infection, destroy and remove bacteria as well as 
damage tissue by phagocytosis. Tsukimi et al. (1996) found that suppression of 
neutrophil infiltration during inflammation could enhance gastric ulcer healing. From 
the current study, H. erinaceus extract may possess anti-inflammatory activity too that 
protects against gastromucosa damage. 
 
4.2.6 Immunohistochemistry analysis in the stomach of rats in ethanol-induced 
ulcer  
Immunohistochemical results showed that rats pre-treated with H. erinaceus 
extract prior to ethanol administration expressed HSP70 protein in high level (Plate 4.5). 
In contrast, expression of HSP70 protein in ethanol-induced gastric tissues (ulcer 
control group) was found to be down regulated compared to HSP70 (70 kilodalton heat 
shock proteins) expression in H. erinaceus extract treated group (Plate 4.5). 
Immunohistochemical staining of Bax protein showed that pre-treatment of ethanol-
induced ulcer with H. erinaceus extract caused down-regulation of Bax protein (Plate 
4.5). Furthermore, up-regulation of Bax in ulcer control group was observed as 
compared to H. erinaceus extract-treated group (Plate 4.5).  
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  Normal control group       Ulcer control group         Omeprazole group      Extract 50mg/kg       Extract 100mg/kg         Extract 200mg/kg Extract 400mg/kg 
  
 
 
Plate 4.5: Immunohistochemical analysis of expression of HSP and Bax proteins in the stomach of rats in ethanol-induced gastric ulcer. Immunohistochemistry  
staining of HSP70 and Bax proteins showed up-regulation of HSP70 protein and down-regulation of Bax protein in rats pretreated with H. erinaceus extract  
(magnification 20×). 
 
 
HSP 
Bax 
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In the present study, there was up-regulation of heat shock protein 70 (HSP70) 
in the ulcerated mucosa of the group treated with H. erinaceus extract (Plate 4.5). This 
finding affirms previous studies which showed an increase in HSP70 expression after 
the damage of the gastric mucosa (Hirakawa et al., 1996; and Schichijo et al., 2003). 
Qiao et al. (2011) also demonstrated that Bax protein was expressed in gastric ischemia-
reperfusion of rats. The level of Bax protein increased in early stage of reperfusion, 
reached its peak at one hour of reperfusion, and decreased gradually after that. 
Apoptosis and proliferation are basic mechanisms for cell death and survival and 
differentiation in the gastric mucosa. Up-regulation of Bax protein induced apoptosis 
and inhibited proliferation. Based on the results, extracts of H. erinaceus may have the 
ability to suppress and inhibit synthesis of Bax protein which may lead to the protection 
of the mushroom extract against irritants in stomach.     
Heat shock proteins, (HSPs) play important roles in normal conditions and 
pathological situations involving both systemic and cellular stress. It have strong 
cytoprotective effects, are involved in many regulatory pathways, and act as molecular 
chaperones for preserving important cellular proteins (Hightower, 1991; and Arya et al., 
2007). In the gastric mucosa, it has been shown that HSP70 had important 
cytoprotective function in in vitro and in vivo (Nakamura et al., 1991; and Itoh & 
Noguchi, 2000).  Our results show significant expression of HSP70 in pre-treated 
mushroom extract. The HSP70 family functions as a molecular chaperone and reduces 
stress-induced denaturation and aggregation of intracellular proteins. Reactive oxygen 
species (ROS) generated by ethanol suppresses the expression of HSP and increase the 
expression of Bax protein. HSP70 proteins protect cells from oxidative stress or heat 
shock. The over expression of HSP70 that was observed in this study could indicate that 
H. erinaceus extract protected the gastric tissues through the upregulation of HSP70. 
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4.2.7 Effect of H. erinaceus in LPO, SOD and CAT enzymes in gastric glandular 
tissue of rats with ethanol-induced ulcer 
 
To determine the effects of antioxidant based defences on the ulceration process, 
the levels of antioxidants (SOD, CAT, and LPO) were evaluated in all stomach tissues. 
Ulcer control group had the highest LPO level (8.89 ± 0.98 µM TEP equivalent) among 
the treated groups (Figure 4.7). As the concentration of H. erinaceus extract was 
increased, the lipid peroxidation level had shown decreasing trend. Hericium erinaceus 
extract at a dose of 50 mg/kg had the highest LPO level (7.46 ± 0.15 µM TEP 
equivalent) among the mushroom extract groups, followed by 100mg/kg (6.83 ± 0.14 
µM TEP equivalent) and 200mg/kg (6.02 ± 0.15 µM TEP equivalent). The result in 
400mg/kg mushroom extract group (5.25 ± 0.07 µM TEP equivalent) showed no 
significant (p < 0.05) difference when compared to omeprazole group (5.44 ± 0.10 µM 
TEP equivalent). The administration of ethanol significantly (p < 0.05) increased the 
LPO level in the stomach tissues of rats in comparison to healthy rats. 
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Figure 4.7: Effect of H. erinaceus extract on LPO production (µM TEP equivalent) in ethanol induced 
ulcer of rats. All values were expressed as mean of three replicate values. Means with different letters 
were significantly different (p < 0.05) by Tukey Test. Six replicates animals were in each treatment group. 
 
 
Figure 4.8 shows production of SOD enzyme in gastric glandular tissue of rats 
with ethanol-induced ulcer. Ulcer control group produced the least amount of SOD 
enzyme (1.89 ± 0.16 U/mg), while H. erinaceus extract produced SOD enzyme in a 
dose dependent manner. Hericium erinaceus extract at a dose of 200mg/kg produced 
three fold of enzyme when compared to 50mg/kg extract. However, there was no 
significant (p < 0.05) difference of SOD enzyme production between omeprazole group 
(5.77 ± 0.20 U/mg) and extract at 200mg/kg (6.24 ± 0.39 U/mg). 
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Figure 4.8: Effect of H. erinaceus extract on SOD production (U/mg of protein) in ethanol induced ulcer 
of rats. All values were expressed as mean of three replicate values. Means with different letters were 
significantly different (P < 0.05) by ANOVA Test. Six replicates animals were in each treatment group. 
 
Catalase enzyme production in stomach of rats with ethanol-induced ulcer is 
shown in Figure 4.9. Hericium erinaceus extract at a dose of 50mg/kg showed the least 
production of catalase enzyme (40.45 ± 2.71 U/mg), whereas non-treatment group had 
the highest production of catalase enzyme (179.24 ± 11.89 U/mg). Mushroom extract 
produced catalase enzyme in a dose dependent manner, whereas extract at a dose of 
200mg/kg produced the highest amount (135.94 ± 6.54 U/mg) of catalase enzyme 
among the mushroom extract groups. This was significantly higher (p < 0.05) when 
compared to rats treated with omeprazole and other doses of mushroom extracts. 
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Figure 4.9: Effect of H. erinaceus extract on CAT production (U/mg protein) in ethanol induced ulcer of 
rats. All values were expressed as mean of three replicate values. Means with different letters were 
significantly different (P < 0.05) by ANOVA Test. Six replicates animals were in each treatment group. 
 
Previous studies have shown that the administration of ethanol decreased the 
levels of SOD and CAT in tissues (Li et al., 2008; and Alimi et al., 2010). Similarly, in 
the present study, the levels of SOD and CAT in rat stomach tissues were significantly 
reduced by the administration of ethanol, and pretreatment with H. erinaceus extracts at 
doses of 200 and 400 mg/kg resulted in decrease on lipid peroxidation (Figure 4.7), and 
a significant increase in the levels of SOD and CAT (Figure 4.8 and Figure 4.9). 
Reactive oxygen species are involved in the pathogenesis of ethanol-induced 
(Pihan et al., 1987) gastric mucosal injury in vivo. Arafa and Sayed-Ahmed (2003) 
found that the production of oxygen-free radicals plays a crucial role in the development 
of ethanol-induced gastric lesions.  Huh et al. (2003) also revealed that free radical 
mechanisms contribute to ethanol-induced tissue injury. Superoxide produced by 
peroxidase in the stomach tissues might damage cell membranes and cause ulcer by 
increasing LPO level (Cadirci et al., 2007). Preventive anti-oxidants, such as superoxide 
e 
cd 
ab 
a 
bc 
d 
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dismutase (SOD) and catalase (CAT) enzymes are the first line of defence against 
reactive oxygen species.  
SOD scavenges the super oxide radical O2
−
, one of the reactive oxygen species 
(ROS) responsible for lipid peroxidation (Fridovich, 1978). This reaction leads to an 
increase in the generation of peroxyl radical H2O2
−
, which is also capable of producing 
more oxidative damage (Das et al., 1997). Catalase and other peroxidases further reduce 
H2O2
−
. In the present study, pre-treatment with H. erinaceus aqueous extract 
significantly decreased LPO and increased SOD and CAT, which indicates its efficacy 
in preventing free radical-induced damage.  
A previous study had demonstrated that basidiocarp of H. erinaceus possess 
antioxidant properties (Wong et al., 2009a). It is probably due to the antioxidant 
property of H. erinaceus that could be linked to its gastroprotective effect. These 
findings reveal that H. erinaceus aqueous extract could have components that prevented 
the formation of ulcer or reduced the severity of ulcer induced by ethanol. Because of 
their antioxidant properties as shown in the present study, their capacity to protect the 
mucosal tissue and their ability to prevent the depletion of antioxidant enzymes it is 
clear that H. erinaceus aqueous extract have gastroprotective activity. 
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4.3  Ulcer healing activity of H. erinaceus extracts in rats with ethanol - induced 
ulcers  
 
4.3.1 Healing effect of H. erinaceus in gross gastric lesions evaluation 
Ulcer treatment with H. erinaceus extract for three days using ethanol-induced 
gastric lesion model is shown in Plate 4.6. Results showed that rats oral-administered 
with omeprazole or H. erinaceus extracts had significantly reduced areas of gastric ulcer 
formation compared with ulcer control group (Plate 4.6b). Both H. erinaceus extracts 
significantly healed the lesions induced by ethanol. It was also observed that healing of 
gastric mucosa was the most prominent in rats treated with 400 mg/kg mushroom 
extract (Plate 4.6e). 
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Plate 4.6: Gross appearance of the gastric mucosa in rats. (a) Rats treated with 5ml/kg distilled water 
(normal control group). Severe injuries are observed in the gastric mucosa. Ethanol produced extensive 
visible hemorrhagic necrosis (arrow) of gastric mucosa. (b) Rats treated with 5ml/kg distilled water (ulcer 
control group). Severe injuries are observed in the gastric mucosa. No healing activity is seen in this 
group. (c) Rats treated with omeprazole (20mg/kg). Injuries to the gastric mucosa are milder compared to 
the injuries seen in the ulcer control rats. (d). Rats treated with H. erinaceus extract (200 mg/kg). Very 
mild injuries are seen in the gastric mucosa. The extract heals the wound on gastric lesions induced by 
ethanol. (e). Rats treated with H. erinaceus extract (400 mg/kg). No injuries are seen in the gastric 
mucosa. The extract heals the wound on gastric lesions induced by ethanol. 
 
a 
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4.3.2 Healing effect of H. erinaceus in the ulcer area in gastric glandular tissue 
 
The healing effect was assessed by animal model. The rats were divided into 
five groups, Group 1 (ethanol only), Group 2 (ethanol + distilled water), Group 3 
(ethanol + Omeprazole), Group 4 (ethanol + H. erinaceus extract 200mg/kg) and Group 
5 (ethanol + H. erinaceus extract 400mg/kg). The results of a three days treatment of 
gastric ulcer induced by 95% ethanol in rats are shown in Figure 4.10. Hericium 
erinaceus extract treated groups had a significantly reduced (p < 0.05) ulcer area than 
that of distilled water and omeprazole groups.  These results showed that in  H. 
erinaceus extract treated groups at a dose of 400mg/kg the ulcer was healed as no ulcer 
was found on the gastric mucosa.  Group 1 animals sacrificed at day zero had the largest 
ulcer area, that is 1436.4 mm
2
. Group 4 (extract treated) animals showed mild 
inflammatory infiltration in the lamina propria, where as in the group 5 animals no ulcer 
area was found. During three days administration of H. erinaceus extract, ulcer area in 
rats were decreased in a dose dependent manner. These results showed strong healing 
effects of H. erinaceus extract which were observed in both the macroscopic and 
morphological analyses of the injuries. Similar result was shown by Mohamad Omar et 
al. (2011). Lentinus squarrosulus completely healed ethanol-induced ulcer rats during 
three days treatment, and found that the mushroom exhibited strong inhibitory action on 
serum IL-1β levels. This cytokine is involved in the induction of inflammation in gastric 
ulcer and as a main factor to induce recurrence of ulcer (Watanabe et al., 2001).  It was 
suggested that bioactive components of H. erinaceus extract may inhibit the production 
of IL-1β and accelerated the rate of ulcer healing in rats. However, this was not 
investigated in this study. Granulation tissue develops at the ulcer base two or three 
days after ulceration [(Tarnawski et al., 1990; Tarnawski et al., 1991; Tarnawski, (1993, 
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2000); and Cotran et al., 1999)]. This may explain rats treated with distilled water was 
significantly lower (p < 0.05) on day three as compared to day one. 
 
 
 
 
 
 
 
 
 
 
4.3.3 Effect of H. erinaceus on mucus production in gastric glandular tissue  
 
4.3.3 Effect of H. erinaceus on mucus production in gastric glandular tissue 
Figure 4.11 demonstrated that the effect of Hericium extracts and omeprazole on 
mucus production at three days treatment after 95% ethanol induced gastric lesion. Rats 
that were treated with omeprazole produced the highest amount of mucus, that is 0.48g 
and followed by group treated with Hericium extract at a dose of 400mg/kg, 0.28g of 
mucus. The gastric mucosa contains many deep as well as surface glands. Chief and 
parietal cells are located in the body and fundus of stomach, while glands in the pyloric 
regions the standard drug and mushroom extract enhance the mucus secretion during the 
Figure 4.10: Effect of H. erinaceus extract on ulcer area in ethanol induced rats after three days 
treatment. All dosages were oral- administered in mg/kg daily. All values were expressed as mean of 
six replicate values. Mean with letters were significantly different (p < 0.05) by tukey Test. Six 
replicates animals were in each treatment group. 
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imbalance. However, both treatment (group 4 and 5) groups did not show significant 
difference (p < 0.05) in mucus production after three days treatment. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Koh and Chen (2000) have suggested that the proton pump inhibitor such as 
omeprazole could inhibit acid secretion and continuously induce production in plasma 
gastrin level thus involved in the regulation of mucosal cell proliferation during ulcer 
healing. Schmassmann and Reubi (2000) demonstrated that during ulcer healing process, 
omeprazole induced hypergastrinaemia, and exogenous gastrin-17 enhanced cell 
Figure 4.11: Effect of H. erinaceus extract on mucus production in ethanol induced rats after three 
days treatment. All dosages were oral- administered in mg/kg daily. All values were expressed as 
mean of six replicate values. Mean with letters were significantly different (p < 0.05) by Tukey Test. 
Six replicates animals were in each treatment group. 
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proliferation in the ulcer margin. From this result, H. erinaceus extract may also possess 
similar activity with omeprazole, which secrete mucus during ulcer healing process. 
 
 
 
 
4.3.4 Effect of H. erinaceus on gastric barrier mucus production in gastric  
glandular tissue of rats with ethanol-induced ulcer  
 
The alcian blue binding capacity in Hericium extracts and omeprazole is shown 
in Figure 4.12. As shown in Figure 4.12, Hericium extract at a dose of 400mg/kg had 
the highest binding capacity of alcian blue, 8.29 µg/g, slightly higher than omeprazole 
group, which had 8.26 µg/g, then followed by 200mg/kg Hericium extract group, which 
recorded 7.58 µg/g. Rats treated with distilled water only had the lowest binding 
capacity of alcian blue after three days treatment. These results showed that Hericium 
extracts produced mucus which play an important role in gastric mucosa defense 
mechanism.  
Laine et al. (2008) stated that mucus play a role in strengthening the mucosal 
barrier. During the healing process, mucus strength should increase or at least 
maintained to protect the regenerating gastric epithelium. Mucus layer protects newly 
formed cells against damage caused by acidic pH and proteolysis from gastric secretions 
(Kobayashi et al., 2001; and Moraes & Hiruma-Lima, 2009). The ability of H. 
erinaceus extracts to induce mucus production promoted the accelerated healing of 
gastric mucosa in ethanol-induced rats.  
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4.3.5 Histological evaluation of gastric lesions 
 
4.3.5 Histological evaluation of gastric lesions in stomachs of control and treated 
rats 
 
Histological observation of ethanol induced gastric lesions in ulcer control group 
treated with distilled water (normal control group) only showed severe damage to the 
epithelium and necrotic lesions penetrate deeply into mucosa, and extensive oedema and 
leucocytes infiltration of the submucosal layer were present (Plate 4.7). Rats that were 
treated with H. erinaceus extract had comparatively better healing effects of the gastric 
Figure 4.12:  Effect of H. erinaceus extract on gastric barrier mucus in ethanol induced rats after three 
days treatment. All dosages were oral- administered in mg/kg daily. All values were expressed as 
mean of six replicate values. Mean with letters were significantly different (p < 0.05) by Tukey Test.  
Six replicates animals were in each treatment group. 
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mucosa as seen by reduction or absence of ulcer area, reduced or absence of submucosal 
edema and leucocytes infiltration (Plate 4.7).  
Laine et al. (2008) stated that the reduction of neutrophils infiltration into 
ulcerated gastric tissues has been related in the promotion of healing of acetic-acid-
induced chronic ulcer in rats. From the histological evaluation (Plate 4.7), it suggested 
that treatment with H. erinaceus extract promoted gastric ulcer healing when compared 
to the normal control group. 
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Plate 4.7: Histological study of ethanol-induced gastric mucosal damage in rats. (a) Rats treated with 
5ml/kg distilled water (normal control group). There is severe disruption to the surface epithelium and 
necrotic lesions penetrating deeply into mucosa and extensive edema of submucosa layer and leucocytes 
infiltration is present. (b) Rats treated with 5ml/kg distilled water (ulcer control group). Moderate damage 
to the surface epithelium is seen. (c) Rats treated with omeprazole (20mg/kg). Mild disruption of the 
surface epithelium mucosa is seen. There is edema and leucocytes infiltration of the submucosal layer. (d) 
Rat treated with H. erinaceus extract (100 mg/kg). Mild disruption of surface epithelium is present. There 
is leucocytes infiltration. (e) Rats treated with H. erinaceus extract (400 mg/kg). There is no disruption to 
the surface epithelium and no edema or leucocytes infiltration of the submucosal layer (H&E stain 10× 
magnification). Notice the leucocytes infiltration in submucosa layer (arrows). 
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Mushrooms such as Lentinula edodes, Pleurotus ostreatus (Bilay et al., 2011), 
Ganoderma lucidum (Gao et al., 2002 and Rony et al., 2011), Lentinus squarrosulus 
(Mohamad Omar et al., 2011), H. erinaceus (Abdulla et al., 2008) are reported to have 
gastroprotective property. However, only G. lucidum (Gao et al., 2002) and L. 
squarrosulus (Mohamad Omar et al., 2011) were shown to heal ethanol-induced gastric 
ulcer in rats.  
In ulcer treatment, the two highest dosages of H. erinaceus extracts, that is 
200mg/kg and 400mg/kg which were used in prevention test were selected. During the 
three days treatment, H. erinaceus extracts significantly (p < 0.05) reduced the ulcer 
area and healed the ulcers on gastric mucosa. 
After ulceration is initiated, ulcer healing starts with a process of coagulation 
and hemostasis. The process is to prevent exsaguination and to provide a matrix for the 
cells coming into the ulcer in the later phase of healing (Chai, 2011). After two or three 
days, the process of granulation tissue formation takes place. Granulation tissue 
comprises of proliferation of connective tissue cells such as macrophage, fibroblast and 
proliferative endothelial cells which form microvessels through angiogenesis process 
(Tarnawski, 2005). Angiogenesis process is an important process in peptic ulcer healing 
and vascular endothelial growth factor (VEGF) is an important regulator that is 
involved in this process (Syam et al., 2009). 
Relationship between endothelial cells, platelets, coagulation, and fibrinolysis 
determines hemostasis and regulates the amount of fibrin deposited at the injury site, 
thus, the progress of healing were influenced by these factors. Growth factors, such as 
platelet derived growth factor (PDGF), transforming growth factor-β (TGF-β), 
epidermal growth factor (EGF), insulin-like growth factor (IGF), basic fibroblast 
growth factor (bFGF), vascular endothelial growth factor (VEGF), Tumor necrosis 
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factor-α (TNF-α), interleukin-1 (IL-1), and interleukin-6 (IL-6) are major stimulators for 
cells to go through proliferation, mitosis, migration, and re-epithelization (Chai, 2011). 
They act as promoters in the ulcer healing by activating and attracting neutrophils, 
macrophages, endothelial cells, fibroblasts and myofibroblasts to the ulcer area, and 
then bring the healing process to the inflammation phase. The inflammatory phase ends 
when lymphocytes are attracted to the ulcer by IL-1, an important regulator of 
collagenase activity that is later needed for extracellular matrix (ECM) remodelling.  
ECM made of fibrous structural proteins such as the collagens and elastins, 
adhesive glycoproteins including fibronectin and laminin and an amorphous gel 
composed of proteoglycans and hyaluronan will form an interstitial matrix and the 
basement membrane (Basson et al., 1993; Cotran et al., 1999; and Basson, 2001). Later 
phase, ECM proteins will be degraded and replaced by matrix metalloproteinases 
(MMPs). Activated MMPs are inhibited by their antagonists, tissue inhibitors of 
metalloproteinase (TIMP), which can be found in most mesenchymal cells, thus 
preventing uncontrolled action of these proteinases (Cotran et al., 1999; and Calabro et 
al., 2004). Both proteins are important in the remodelling of connective tissue necessary 
for the tissue defect repair and scar formation (Shanin et al., 2001; and Calabro et al., 
2004). 
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5.0 Recommendations for further studies and conclusions 
In the present study, the potential efficacy of the mushroom  
H. erinaceus to protect and / or heal the gastric ulcer in rats experimentally induced by 
ethanol was investigated and compared with. Other models of gastric ulcer induction 
such as Hydrochloric acid (HCl), acetic acid or pylorus ligation methods can be 
conducted in the future. Other than that, biomarkers such as NF-kB, Interleukin-1β, 
TNF-α, PGE2, NO and COX-2 can also be investigated to aid in understanding of the 
healing mechanism/s. Another staining method, Periodic acid-Schiff (PAS) staining can 
be alternative choice to evaluate the mucus secretion, which form a mucus layer to 
protect gastric mucosa against physical damage.  
Furthermore, double-boiled aqueous extract was used in this study. Aqueous 
extract can be further purified to obtain pure compounds so that specific compounds 
which have effect on gastric ulcer treatment can be identified. Since aqueous extraction 
mainly release primary active compounds such as polysaccharides or beta glucans, 
solvents such as methanol and ethanol can be used to extract H. erinaceus basidiocarp 
to obtain secondary metabolites. Through alcohol extraction, secondary metabolite such 
as triterpenoids, which are believed to have anti-inflammatory property, may be 
obtained. 
In conclusion, Hericium erinaceus did not show any sign of toxicological effects 
on rats during 14 days at a dose of 2 and 5 g/kg. Hericium erinaceus extract had 
gastroprotective activity in a dose dependent manner and produced mucus which is 
important in gastric defense mechanism. At 400mg/kg, there was a significant (p < 0.05) 
reduction of ulcer areas in the gastric wall as well as by the reduction or inhibition of 
edema and leukocytes infiltration of the submucosal layers which were shown 
histologically. Immunohistochemistry staining of HSP70 and Bax proteins showed up-
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regulation of HSP70 protein and down-regulation of Bax protein in rats pre-treated with 
mushroom extract, in a dose dependent manner.  
Beside that, H. erinaceus extract also significantly increased the SOD and CAT 
and decreased the level of lipid peroxidation (LPO) in gastric tissue homogenates. 
Among the extract concentrations, highest SOD and CAT enzyme activity were shown 
at 200mg/kg dose. In addition, H. erinaceus extract at 400mg/kg had the lowest LPO 
activity, and this result was comparable to omeprazole group.  
During the three days ulcer treatment experiment, H. erinaceus extract at a dose 
of 400mg/kg could significantly (p < 0.05) heal the ulcer that was induced by ethanol in 
rats. No ulcer was observed after three days treatment and significantly higher (p < 0.05) 
mucus content was present when compared to extract at 200mg/kg dosage. 
Hericium erinaceus, a well-documented temperate mushroom that is beneficial 
for gastrointestinal health in Chinese medicine is now grown in Malaysia.  The 
gastroprotection and ulcer healing effects are retained though mushroom is grown at 
much higher temperatures in tropical Malaysia. All these results suggest the safety and 
efficacy of H. erinaceus either in preventing or healing gastric ulcer.  
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Appendix A: Analytical Methods 
a) Gastric mucus barrier 
Dissolve 1g of alcian blue in 100ml dH2O, do a series of two times dilution. Rats 
stomach tissue homogenated in PBS buffer at a 1:8 ratio, that is 1g of tissue 
homogenated in 8 ml of PBS buffer. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Concentration (g/ml, x10
-6
) Absorbance at 580nm 
1.9 0.0825 
3.9 0.1305 
7.8 0.167 
15.6 0.271 
31.2 0.487 
113 
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b) Bradford Test 
Prepare stock standard 1mg/ml (5mg/5ml) of BSA 
Prepare three to five times dilution 
1mg/ml  
0.5mg/ml 
0.1mg/ml 
0.05mg/ml 
 
 
 
 
 
 
 
 
 
 
 
 
Concentration of protein (mg/ml) Absorbance at 595nm 
0 0 
0.05 0.06633 
0.1 0.197667 
0.25 0.407667 
0.5 0.663 
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Standard curve of Bradford was plotted after five times dilution of tissue homogenated 
solution. 
c) Lipid peroxidation assay: Standard preparation 
   12.5 µl TEP/ 50ml dH2O   
     
        20 µM 
 
  10µM                 15 µM 
 
  5 µM 
 
  2.5 µM 
2x dilution 
2x dilution 
2x dilution 
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Reagent preparation 
15% TCA : Dissolve 6g of TCA in 40ml dH2O 
1% TBA :  Dissolve 0.4g of TBA in 40ml dH2O 
Concentration of TEP (µm) Absorbance at 532 nm 
0 0 
2.5 0.06 
5 0.123 
10 0.25 
15 0.332 
20 0.409 
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d) SOD 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SOD activity (U/ml) Linearized rate 
0 1 
0.025 1.243644 
0.05 1.262366 
0.1 1.56117 
0.15 1.869427 
0.2 1.989831 
0.25 2.530172 
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Standard curve of SOD  
 
SOD (U/ml) =  
 
 
e) CAT 
Formaldehyde (µM) Absorbance at 540 nm 
0 0 
5 0.096 
15 0.1875 
30 0.262 
45 0.4185 
60 0.48 
75 0.7405 
 
 
 
 
 
[(            )      ]    
Sample LR – y-intercept 
 slope x 
0.23 ml 
0.01 ml x
 Sample 
dilution 
119 
 
 
 
 
 
 
 
 
 
Formaldehyde (µM) =  
 
 
CAT Activity =                                           Sample dilution = nmol/min/ml 
 
f) Histological technique 
1. Specimen preparation 
 Trim tissue into small size. 
 Insert the trimming tissue into cassette and label properly. 
 Place the cassettes in the 10% buffered formalin. 
 
[                ]    
Sample absorbance – (y-intercept) 
  slope 
x 
0.17 ml 
0.02 ml 
µM of sample 
     20 min. 
x 
120 
 
2. Automated tissue processing 
Process Duration (hours) 
Dehydration 
1. 10% Formalin 
2. 10% Formalin 
3. 70% Ethanol 1 
4. 95% Ethanol 2 
5. 95% Ethanol 3 
6. 95% Ethanol 4 
7. Absolute Ethanol 1 
8. Absolute Ethanol 2 
 
1 
1 
1 
1 
1 
1 
1 
11/2 
CLEARING 
9. Alcohol :Xylene (1:1) 
10. Xylene 1 
11. Xylene 2 
 
1 
11/2 
11/2 
EMBEDDING 
12. Paraffin Wax 1 
13. Paraffin Wax 1 
 
11/2 
11/2 
TOTAL 141/2 
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3. Tissue blocking 
 Place the tissue in mold properly 
 Load the paraffin wax into the mold. 
 Place the mold on cold plate area and wait until it solidifies. 
4. Sectioning 
 Section the tissue blocking by using a rotary microtome to a thickness of 5 µm. 
 Put the ribbon section onto 42 °C water bath. 
 Pick the best tissue section on water bath by using clean glass slide. 
 Dehydrate the slides in an oven at 55°C for at least 24 hours. 
5. Staining 
a) Haematoxylin and Eosin staining 
 
Process (solution) Time duration (minutes) 
DEWAXING 
1. Xylene 1 
2. Xylene 1 
 
3 
3 
REHYDRATION 
3. Absolute Alcohol 
4. 95%Alcohol 1 
5. 95%Alcohol 2 
6. 70%Alcohol 
 
2 
2 
2 
2 
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BRING SECTION TO WATER 
(RUNNING WATER ) 
3 
STAINING 
7. Harrls’ Haematoxylin 
8. Running Water 
9. 0.5% Acid Alcohol 
10. Running Water 
11. 2% Sodium Acetate 
12. Running Water 
13. Rinse in 80% Alcohol 
14. Eosin 
 
10 minutes 
Remove excess colour 
2-3 dips 
2-3 minutes 
2 second 
2-3 minutes 
2-3 dips 
5 minutes 
DEHYDATION 
15. 95%Alcohol 1 
16. 95%Alcohol 2 
17. Absolute Alcohol 1 
18. Absolute Alcohol 2 
 
5 second 
2 minutes 
2 minutes 
2 minutes 
CLEARING 
19. Xylene 1 
20. Xylene 2 
21. Xylene 3 
 
2 minutes 
2 minutes 
3 minutes 
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b) Immunohistochemistry staining 
Process (solution) Time duration 
(minutes) 
DEWAXING 
1. Xylene 1 
2. Xylene 2 
3. Xylene 3 
 
 
5  
5  
5  
REHYDRATION 
4. 95%Alcohol  
5. 85%Alcohol  
6. 70%Alcohol 
7. Distilled water 
 
20 dips 
20 dips 
20 dips 
5 minutes 
WASHING 
8. Soak in 10X TBS wash buffer and heat in oven at low 
temperature. 
9. Cool down in room temperature 
10. Tap off excess TBS buffer. 
11. Use lintless tissue to wipe around the specimen. 
 
 
20 
STAINING 
i) Peroxidase block 
 Tap off excess wash buffer. Using a lintless tissue to 
wipe around the specimen. 
 
 
5  
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 Apply Peroxidase block to cover specimen 
 Incubate  
 Rinse gently with distilled water 
 
ii) Biotinylated primary antibody 
 Wipe slides as before. 
 Apply prepared biotinylated primary antibody to cover 
specimen 
 Incubate  
 Rinse gently with wash buffer and place in buffer bath 
 
iii) Streptavidin peroxidase 
 Wipe slides as before. 
 Apply Streptavidin peroxidase to cover specimen 
 Incubate  
 Rinse gently with wash buffer and place in buffer bath 
 
 
iv) DAB+ substrate chromogen 
 Wipe slides as before 
 Apply prepared DAB+ substrate chromogen to cover 
specimen. 
 Incubate                  
 Rinse gently with distilled water from wash bottle 
 
 
 
15  
 
 
 
15 
 
 
10 dips 
2-5 minutes 
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v) Haematoxylin counterstain 
 Immerse slides in a bath of haematoxylin. 
 0.037mol/L ammonia 
 Rinse slides in a bath of distilled water  
 
 
6. Mounting 
 
Mount stained tissue with DPX mounting media and cover the tissue with cover slip and 
wipe the slide to remove excess xylene and then observed under light microscope. 
 
Flow chart of histological technique 
 
     
 
 
 
 
 
 
 
Preparation of specimen 
Automated tissue processing 
Tissue blocking 
Sectioning  
Staining 
Mounting  
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Appendix B: Results of Experiments 
a) Acute toxicity test 
i) Body weight of rat 
Table 1. Descriptive: body weight of male rats in control group (Treatment) 
 
Table 2. ANOVA: body weight of male rats in control group (Treatment) 
 
 
 
 
 
 
 
 
N Mean 
Std. 
Deviation 
Std. 
Error 
95% Confidence 
Interval for Mean Minimum Maximum 
     Lower 
Bound 
Upper 
Bound 
  
Day 
0 
6 247.5000 33.88067 13.83173 211.9444 283.0556 190.00 280.00 
Day 
7 
6 278.6667 29.83063 12.17830 247.3613 309.9720 230.00 305.00 
Day 
14 
6 288.6667 28.40892 11.59789 258.8533 318.4800 241.00 313.00 
Total 18 271.6111 34.09009 8.03511 254.6585 288.5637 190.00 313.00 
 Sum of 
Squares 
df Mean Square F Sig. 
Between 
Groups 
 
5532.111 2 2766.056 2.917 .085 
Within 
Groups 
14224.167 15 948.278 
  
Total 19756.278 17 
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Table 3. Multiple range tests: body weight of male rats in control group  
(Treatment) 
 
 
Means for groups in homogeneous subsets are displayed. 
 a. Uses Harmonic Mean Sample Size = 6.000. 
 
Table 4. Descriptive: body weight of male rats in low dose group 
 
 N 
Mean 
Std. 
Deviation 
Std. 
Error 
95% Confidence 
Interval for Mean Minimum Maximum 
 
    Lower 
Bound 
Upper 
Bound 
  
Day 
0 
6 226.0000 13.84197 5.65096 211.4737 240.5263 210.00 242.00 
Day 
7 
6 247.6667 15.40995 6.29109 231.4949 263.8384 225.00 263.00 
Day 
14 
6 250.1667 19.23972 7.85458 229.9758 270.3575 225.00 270.00 
Total 18 241.2778 18.96686 4.47053 231.8458 250.7098 210.00 270.00 
 
 
 
 
 
 
 
 
 
 
 
 
 
Group N 
Subset for alpha = 0.05 
1 
2 
Tukey HSD
a
 Day 0 
6 247.5000  
 Day 7 6 278.6667  
 Day 14 6 288.6667  
 Sig.  .084  
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Table 5. ANOVA: body weight of male rats in low dose group 
 
 
 
Table 6. Multiple range tests: body weight of male rats in low dose group 
 
Tukey HSD
a
 Group N Subset for alpha = 0.05 
1 2 
Day 0 6 226.0000 
 
Day 7 6 247.6667 
 
Day 14 6 250.1667 
 
Sig. 
 
.053 
 
 
 
 
 
Table 7. Descriptive: body weight of male rats in high dose group 
 
 
N Mean Std. 
Deviation 
Std. 
Error 
95% Confidence 
Interval for Mean 
Minimum Maximum 
     Lower 
Bound 
Upper 
Bound 
  
Day 
0 
6 229.3333 38.89302 15.87801 188.5176 270.1491 176.00 280.00 
Day 
7 
6 262.5000 46.51344 18.98903 213.6871 311.3129 203.00 319.00 
Day 
14 
6 268.8333 49.32917 20.13855 217.0655 320.6011 204.00 325.00 
Total 18 253.5556 45.98494 10.83875 230.6878 276.4233 176.00 325.00 
 
 
 
Sum of 
Squares 
df 
Mean 
Square 
F Sig. 
Between 
Groups 
2119.444 2 1059.722 3.978 .041 
Within 
Groups 
3996.167 15 266.411   
Total 6115.611 17    
Means for groups in homogeneous subsets are displayed. 
a. Uses Harmonic Mean Sample Size = 6.000. 
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Table 8. ANOVA: body weight of male rats in high dose group 
 
Table 9. Multiple range tests:  body weight of male rats in high dose group 
 
 
Group N Subset for alpha = 0.05 
  1 
Tukey HSD
a
 Day 0 6 229.3333 
 Day 7 6 262.5000 
 Day 14 6 268.8333 
 Sig. 
 
.312 
 
Means for groups in homogeneous subsets are displayed. 
a. Uses Harmonic Mean Sample Size = 6.000. 
Table 10. Descriptive: body weight of female rats in control group 
 
 
 
 Sum of 
Squares 
df Mean Square F Sig. 
Between 
Groups 
5400.778 2 2700.389 1.326 .295 
Within 
Groups 
30547.667 15 2036.511 
  
Total 35948.444 17 
   
  N Mean Std. 
Deviation 
Std. 
Error 
95% Confidence 
Interval for Mean 
Minimum Maximum 
      Lower 
Bound 
Upper 
Bound 
  
Day 0  6 186.3333 19.68417 8.03603 165.6761 206.9906 164.00 213.00 
Day 7  6 189.6667 23.12286 9.43987 165.4007 213.9326 167.00 219.00 
Day 
14 
 6 195.5000 17.87456 7.29726 176.7418 214.2582 175.00 220.00 
Total  18 190.5000 19.50339 4.59699 180.8012 200.1988 164.00 220.00 
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Table 11. ANOVA: body weight of female rats in control group 
 
 
 
Sum of 
Squares 
df Mean Square F Sig. 
Between 
Groups 
 
 
258.333 2 129.167 .312 .737 
Within 
Groups 
 
 
6208.167 15 413.878 
  
Total  6466.500 17 
   
 
 
 
 
Table 12. Multiple range tests: body weight of female rats in control group 
 
 
Means for groups in homogeneous subsets are displayed. 
a. Uses Harmonic Mean Sample Size = 6.000. 
 
Table 13. Descriptive: body weight of female rats in low dose group 
 
 
N Mean Std. 
Deviation 
Std. 
Error 
95% Confidence 
Interval for Mean 
Minimum Maximum 
     Lower 
Bound 
Upper 
Bound 
  
Day 
0 
6 216.3333 24.56556 10.02885 190.5534 242.1133 188.00 257.00 
Day 
7 
6 218.1667 22.82469 9.31814 194.2136 242.1197 194.00 253.00 
Day 
14 
6 224.0000 18.06654 7.37564 205.0403 242.9597 204.00 250.00 
Total 18 219.5000 20.92915 4.93305 209.0922 229.9078 188.00 257.00 
 
 
Group N 
Subset for alpha = 0.05 
               1 
Tukey HSD
a
 Day 0 6 186.3333 
 Day 7 6 189.6667 
 Day 14 6 195.5000 
 Sig. 
 
.720 
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Table 14. ANOVA: body weight of female rats in low dose group 
 
 
Sum of 
Squares 
df Mean Square F Sig. 
Between 
Groups 
192.333 2 96.167 .199 .822 
Within 
Groups 
7254.167 15 483.611   
Total 7446.500 17    
 
 
Table 15. Multiple range tests: body weight of female rats in low dose group 
 
 
 
Group N Subset for alpha = 0.05 
1 
Tukey HSD
a
 Day 0 6 216.3333 
 Day 7 6 218.1667 
 Day 14 6 224.0000 
 Sig. 
 
.820 
 
 
 
Means for groups in homogeneous subsets are displayed. 
a. Uses Harmonic Mean Sample Size = 6.000. 
 
Table 16. Descriptive: body weight of female rats in high dose group 
 
 N Mean Std. 
Deviation 
Std. 
Error 
95% Confidence 
Interval for Mean 
Minimum Maximum 
      Lower 
Bound 
Upper 
Bound 
  
Day 0  6 199.8333 16.00521 6.53410 183.0369 216.6298 168.00 212.00 
Day 7  6 202.6667 16.39105 6.69162 185.4653 219.8680 174.00 222.00 
Day 
14 
 6 207.3333 14.69240 5.99815 191.9146 222.7521 180.00 221.00 
Total  18 203.2778 15.09891 3.55885 195.7693 210.7863 168.00 222.00 
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Table 17. ANOVA: body weight of female rats in high dose group 
 
 Sum of 
Squares 
df Mean Square F Sig. 
Between 
Groups 
172.111 2 86.056 .349 .711 
Within Groups 3703.500 15 246.900   
Total 3875.611 17    
 
 
Table 18. Multiple range tests: body weight of female rats in high dose group 
 
 
Group N Subset for alpha = 0.05 
1 
Tukey HSD
a
 Day 0 6 199.8333 
 Day 7 6 202.6667 
 Day 14 6 207.3333 
 Sig. 
 
.693 
 
Means for groups in homogeneous subsets are displayed. 
a. Uses Harmonic Mean Sample Size = 6.000. 
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ii) Biochemical tests 
Parameters that showed significantly different only displayed as below: 
Table 19. Descriptive: Renal function test of male rats in potassium (mmol/L) 
 
 
N Mean 
Std. 
Deviatio
n 
Std. 
Error 
95% Confidence 
Interval for Mean 
Minimum Maximum 
Lower 
Bound 
Upper 
Bound 
G1 6 4.7667 .15055 .06146 4.6087 4.9247 4.60 5.00 
G2 6 5.0833 .20412 .08333 4.8691 5.2975 4.90 5.30 
G3 6 5.0833 .23166 .09458 4.8402 5.3264 4.80 5.50 
Total 18 4.9778 .24146 .05691 4.8577 5.0979 4.60 5.50 
 
Table 20. ANOVA: Renal function test of male rats in potassium (mmol/L) 
 
 
Table 21. Multiple range tests: Renal function test of male rats in potassium 
(mmol/L) 
 
 
Group N 
Subset for alpha = 0.05 
1 2 
Tukey HSD
a
 G1 6 4.7667  
 G3 6  5.0833 
 G2 6  5.0833 
 Sig. 
 
1.000 1.000 
Means for groups in homogeneous subsets are displayed. 
a. Uses Harmonic Mean Sample Size = 6.000. 
 
 Sum of Squares df. Mean Square F Sig. 
Between Groups .401 2 .201 5.099 .020 
Within Groups .590 15 .039 
  
Total .991 17 
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Table 22. Descriptives: Liver function test of male rats in Alanine 
Aminotransferase (IU/L) 
 
N Mean 
Std. 
Deviatio
n 
Std. 
Error 
95% Confidence 
Interval for Mean 
Minimum Maximum 
Lower 
Bound 
Upper 
Bound 
G1 6 51.8333 4.70815 1.92209 46.8924 56.7742 45.00 58.00 
G2 6 48.0000 1.41421 .57735 46.5159 49.4841 46.00 50.00 
G3 6 46.5000 3.56371 1.45488 42.7601 50.2399 42.00 50.00 
Total 18 48.7778 4.02281 .94819 46.7773 50.7783 42.00 58.00 
 
 
Table 23. ANOVA: Liver function test of male rats in Alanine Aminotransferase 
(IU/L) 
 
Table 24. Multiple range tests:  Liver function test of male rats in Alanine 
Aminotransferase (IU/L) 
 
 
Group N 
Subset for alpha = 0.05 
1 2 
Tukey HSD
a
 G3 6 46.5000  
 G2 6 48.0000 48.0000 
 G1 6  51.8333 
 Sig.  .743 .175 
Means for groups in homogeneous subsets are displayed. 
a. Uses Harmonic Mean Sample Size = 6.000. 
 Sum of Squares df. Mean Square F Sig. 
Between Groups 90.778 2 45.389 3.693 .050 
Within Groups 184.333 
15 12.289   
Total 275.111 17    
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Table 25. Descriptives: Liver function test of female rats in Alkaline Phosphatase 
(IU/L) 
 
N Mean 
Std. 
Deviation 
Std. 
Error 
95% Confidence 
Interval for Mean 
Minimum Maximum 
Lower 
Bound 
Upper 
Bound 
G1 6 114.8333 24.73392 10.09758 88.8767 140.7900 84.00 159.00 
G2 6 72.8333 12.63988 5.16021 59.5686 86.0981 53.00 89.00 
G3 6 94.0000 17.50429 7.14609 75.6304 112.3696 75.00 125.00 
Total 18 93.8889 25.06671 5.90828 81.4235 106.3543 53.00 159.00 
 
Table 26. ANOVA: Liver function test of female rats in Alkaline Phosphatase 
(IU/L) 
 
Table 27. Multiple range tests: Liver function test of female rats in Alkaline 
Phosphatase (IU/L) 
 
Group N 
Subset for alpha = 0.05 
1 2 
Tukey HSD
a
 G2 6 72.8333  
 G3 6 94.0000 94.0000 
 G1 6  114.8333 
 Sig.  .163 .172 
Means for groups in homogeneous subsets are displayed. 
a. Uses Harmonic Mean Sample Size = 6.000. 
 
 Sum of Squares df. Mean Square F Sig. 
Between Groups 
5292.111 2 2646.056 7.364 .006 
Within Groups 
5389.667 15 359.311   
Total 10681.778 17    
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b) Ulcer prevention:  
i) Ulcer area  
 
Table 28. Descriptives: ulcer area of rats in ulcer prevention test 
 N Mean Std. 
Deviation 
Std. 
Error 
95% Confidence 
Interval for Mean 
Minimum Maximum 
Lower 
Bound 
Upper 
Bound 
Positive 
Group 
6 285.6000 48.11985 19.64485 235.1013 336.0987 223.20 360.00 
Negative 
Group 
6 894.0000 89.86069 36.68547 799.6970 988.3030 756.00 993.60 
50mg/kg 
Group 
6 727.2000 65.83179 26.87571 658.1138 796.2862 640.80 806.40 
100mg/kg 
Group 
6 602.4000 72.09594 29.43304 526.7400 678.0600 504.00 720.00 
200mg/kg 
Group 
6 453.6000 68.30520 27.88548 381.9181 525.2819 367.20 525.60 
400mg/kg 
Group 
6 240.0000 42.39245 17.30665 195.5118 284.4882 172.80 280.80 
Total 36 533.8000 244.31641 40.71940 451.1352 616.4648 172.80 993.60 
 
 
Table 29. ANOVA: ulcer area of rats in ulcer prevention test 
 
 
 
Sum of Squares df Mean Square F Sig. 
Between Groups 
1957243.680 5 391448.736 89.017 .000 
Within Groups 
131924.160 30 4397.472   
Total 
2089167.840 35    
 
 
 
 
 
 
 
137 
 
Table 30. Multiple range tests: ulcer area of rats in ulcer prevention test 
 
 
 Group N Subset for alpha = 0.05 
1 2 3 4 5 
Tukey 
HSD
a
 
400mg/kg Group 6 240.0000 
    
 Positive Group 6 285.6000 
    
 200mg/kg Group 6 
 
453.6000 
   
 100mg/kg Group 6 
  
602.4000 
  
 50mg/kg Group 6 
   
727.2000 
 
 Negative Group 6 
    
894.0000 
 Sig. 
 
.838 1.000 1.000 1.000 1.000 
 
Means for groups in homogeneous subsets are displayed. 
a. Uses Harmonic Mean Sample Size = 6.000. 
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ii) Mucus content 
Table 31. Descriptives: mucus content of rats in ulcer prevention test 
 
Table 32. ANOVA: mucus content of rats in ulcer prevention test 
 
 Sum of Squares df Mean Square F Sig. 
Between Groups 4.534 6 .756 52.093 .000 
Within Groups .508 35 .015   
Total 5.041 41    
 
 
 
 
 
 
 
 
 
 N Mean Std. 
Deviation 
Std. 
Error 
95% Confidence 
Interval for Mean 
Minimum Maximum 
Lower 
Bound 
Upper 
Bound 
Normal 
Group 
6 .4271 .14234 .05811 .2777 .5765 .21 .59 
Positive 
Group 
6 1.5557 .16984 .06934 1.3774 1.7339 1.37 1.85 
Negative 
Group 
6 .7988 .07577 .03093 .7193 .8783 .70 .89 
50mg/kg 
Group 
6 .7961 .07279 .02971 .7197 .8725 .70 .90 
100mg/kg 
Group 
6 .8207 .09700 .03960 .7189 .9225 .64 .93 
200mg/kg 
Group 
6 .9266 .15024 .06133 .7689 1.0842 .76 1.15 
400mg/kg 
Group 
6 1.1833 .09702 .03961 1.0815 1.2851 1.04 1.32 
Total 42 .9297 .35066 .05411 .8205 1.0390 .21 1.85 
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Table 33. Multiple range tests: mucus content of rats in ulcer prevention test 
 
 Group N Subset for alpha = 0.05 
1 2 3 4 
Tukey HSD
a
 Normal Group 6 .4271 
   
 50mg/kg Group 6  .7961 
  
 Negative Group 6  .7988 
  
 100mg/kg Group 6  .8207 
  
 200mg/kg Group 6  .9266 
  
 400mg/kg Group 6  
 
1.1833 
 
 Positive Group 6  
  
1.5557 
 Sig.  1.000 .509 1.000 1.000 
 
Means for groups in homogeneous subsets are displayed. 
a. Uses Harmonic Mean Sample Size = 6.00 
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iii) Alcian blue 
Table 34. Descriptives: alcian blue of rats in ulcer prevention test 
 
 
Table 35. ANOVA: alcian blue of rats in ulcer prevention test 
 
 Sum of Squares df Mean Square F Sig. 
Between Groups 401.495 6 66.916 30.543 .000 
Within Groups 76.681 35 2.191   
Total 478.176 41    
 
 
N 
 
Mean 
Std. 
Deviation 
Std. 
Error 
95% Confidence 
Interval for Mean 
Minimum Maximum 
Lower 
Bound 
Upper 
Bound 
Non 
Treatment 
Group 
6 5.0099 1.12988 .46127 3.8241 6.1956 3.21 6.10 
Positive 
Group 
6 6.7259 1.64754 .67261 4.9969 8.4549 4.91 9.13 
Negative 
Group 
6 3.4173 .31572 .12889 3.0860 3.7486 2.84 3.80 
Extract 
50mg/kg 
Group 
6 8.0963 1.70917 .69777 6.3026 9.8900 6.17 10.24 
Extract 
100mg/kg 
Group 
6 11.1951 1.09611 .44749 10.0448 12.3454 9.87 12.76 
Extract 
200mg/kg 
Group 
6 12.2938 1.49231 .60923 10.7277 13.8599 10.02 14.02 
Extract 
400mg/kg 
Group 
6 10.6395 2.21265 .90331 8.3175 12.9615 8.39 13.58 
Total 42 8.1968 3.41509 .52696 7.1326 9.2610 2.84 14.02 
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Table 36. Multiple range tests: alcian blue of rats in ulcer prevention test 
 
 
Means for groups in homogeneous subsets are displayed. 
a. Uses Harmonic Mean Sample Size = 6.000. 
 
 
 
 
 
 
 
 
 
 
 
 Group N Subset for alpha = 0.05 
1 2 3 4 5 
Tukey 
HSD
a
 
Negative Group 6 3.4173 
    
 Non Treatment 
Group 
6 5.0099 5.0099 
   
 Positive Group 6 
 
6.7259 6.7259 
  
 Extract 50mg/kg 
Group 
6 
  
8.0963 8.0963 
 
 Extract 400mg/kg 
Group 
6 
   
10.6395 10.6395 
 Extract 100mg/kg 
Group 
6 
    
11.1951 
 Extract 200mg/kg 
Group 
6 
    
12.2938 
 Sig. 
 
.517 .428 .681 .071 .472 
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iv) LPO 
Table 37. Descriptives: LPO of rats in ulcer prevention test 
 
 
N Mean 
Std. 
Deviation 
Std. 
Error 
95% Confidence 
Interval for 
Mean 
Minimum Maximum 
Lower 
Bound 
Upper 
Bound 
Non 
Treatment 
Group 
3 4.4300 .12781 .07379 4.1124 4.7475 4.29 4.53 
Positive 
Group 
3 5.4444 .17418 .10056 5.0118 5.8771 5.30 5.64 
Negative 
Group 
3 8.8905 .16966 .09795 8.4691 9.3119 8.73 9.07 
Extract 
50mg/kg 
Group 
3 7.4573 .26607 .15361 6.7964 8.1183 7.18 7.71 
Extract 
100mg/kg 
Group 
3 6.8293 .24790 .14313 6.2135 7.4451 6.56 7.04 
Extract 
200mg/kg 
Group 
3 6.0242 .25563 .14759 5.3891 6.6592 5.73 6.22 
Extract 
400mg/kg 
Group 
3 5.2512 .12781 .07379 4.9337 5.5687 5.11 5.35 
Total 21 6.3324 1.44504 .31533 5.6746 6.9902 4.29 9.07 
 
Table 38. ANOVA: LPO of rats in ulcer prevention test 
 
 Sum of Squares df Mean Square F Sig. 
Between Groups 41.184 6 6.864 166.033 .000 
Within Groups .579 14 .041   
Total 41.763 20    
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Table 39. Multiple range tests: LPO of rats in ulcer prevention test 
 
 
Means for groups in homogeneous subsets are displayed. 
a. Uses Harmonic Mean Sample Size = 3.000. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Group N 
 Subset for alpha = 0.05 
1 2 3 4 5 6 
Tukey 
HSD
a
 
Non Treatment 
Group 
3 4.4300 
     
 Extract 400mg/kg 
Group 
3 
 
5.2512 
    
 Positive Group 3 
 
5.4444 
    
 Extract 200mg/kg 
Group 
3 
  
6.0242 
   
 Extract 100mg/kg 
Group 
3 
   
6.8293 
  
 Extract 50mg/kg 
Group 
3 
    
7.4573 
 
 Negative Group 3 
     
8.8905 
 Sig. 
 
1.000 .896 1.000 1.000 1.000 1.000 
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v) SOD 
Table 40. Descriptives: SOD of rats in ulcer prevention test 
 
 
Table 41. ANOVA: SOD of rats in ulcer prevention test 
 
 Sum of Squares df Mean Square F Sig. 
Between Groups 105.725 6 17.621 78.550 .000 
Within Groups 3.141 14 .224   
Total 108.866 20    
 
 
N 
 
Mean 
 
Std. 
Deviation 
 
Std. 
Error 
 
95% Confidence 
Interval for 
Mean 
Minimum 
 
Maximum 
 
Lower 
Bound 
Upper 
Bound 
Non 
Treatment 
Group 
3 
8.8161 .53526 .30903 7.4865 10.1458 8.26 9.33 
Positive Group 3 5.7701 .34725 .20049 4.9074 6.6327 5.37 5.98 
Negative 
Group 
3 
1.8890 .28329 .16356 1.1852 2.5927 1.64 2.20 
Extract 
50mg/kg 
Group 
3 
2.1032 .25757 .14871 1.4633 2.7430 1.90 2.39 
Extract 
100mg/kg 
Group 
3 
4.3537 .58925 .34021 2.8899 5.8175 3.95 5.03 
Extract 
200mg/kg 
Group 
3 
6.2390 .66930 .38642 4.5764 7.9016 5.54 6.87 
Extract 
400mg/kg 
Group 
3 
5.3168 .47054 .27167 4.1480 6.4857 4.79 5.69 
Total 21 4.9268 2.33308 .50912 3.8648 5.9888 1.64 9.33 
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Table 42. Multiple range tests: SOD of rats in ulcer prevention test 
 
Means for groups in homogeneous subsets are displayed. 
a. Uses Harmonic Mean Sample Size = 3.000. 
 
 
 
 
 
 
 
 
 
 
 
Group N 
Subset for alpha = 0.05 
1 2 3 4 5 
Tukey 
HSD
a
 
Negative Group 3 1.8890     
 Extract 50mg/kg 
Group 
3 2.1032     
 Extract 100mg/kg 
Group 
3  4.3537    
 Extract 400mg/kg 
Group 
3  5.3168 5.3168   
 Positive Group 3   5.7701   
 Extract 200mg/kg 
Group 
3   6.2390   
 Non Treatment 
Group 
3    8.8161  
 Sig.  .997 .234 .273 1.000  
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vi) CAT 
 
Table 43. Descriptives: CAT of rats in ulcer prevention test 
 
 
 
 
 
 
 
 
 
N 
 
Mean 
 
Std. 
Deviation 
 
Std. 
Error 
 
95% Confidence 
Interval for Mean 
Minimum 
 
Maximum 
 
Lower 
Bound 
Upper 
Bound 
Non 
treatment 
Group 
3 179.2439 20.59684 11.89159 128.0785 230.4093 166.61 203.01 
Positive 
Group 
3 68.5147 6.52168 3.76529 52.3139 84.7154 62.32 75.32 
Negative 
Group 
3 112.1032 15.27800 8.82076 74.1505 150.0558 100.08 129.30 
Extract 
50mg/kg 
Group 
3 40.4522 4.68744 2.70629 28.8080 52.0965 37.60 45.86 
Extract 
100mg/kg 
Group 
3 96.2136 18.41117 10.62970 50.4778 141.9495 83.11 117.26 
Extract 
200mg/kg 
Group 
3 135.9413 11.31900 6.53503 107.8233 164.0592 123.84 146.27 
Extract 
400mg/kg 
Group 
3 126.0888 10.11856 5.84195 100.9529 151.2246 114.56 133.49 
Total 21 108.3654 44.70120 9.75460 88.0176 128.7131 37.60 203.01 
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Table 44. ANOVA: CAT of rats in ulcer prevention test 
 
 Sum of Squares df Mean Square F Sig. 
Between Groups 37380.684 6 6230.114 33.764 .000 
Within Groups 2583.256 14 184.518   
Total 39963.940 20    
 
Table 45. Multiple range tests: CAT of rats in ulcer prevention test 
 
 
Means for groups in homogeneous subsets are displayed. 
a. Uses Harmonic Mean Sample Size = 3.000.  
 
 
 
 
Group N 
Subset for alpha = 0.05 
1 2 3 4 5 
Tukey 
HSD
a
 
Extract 50mg/kg 
Group 
3 40.4522     
 Positive Group 3 68.5147 68.5147    
 Extract 100mg/kg 
Group 
3  96.2136 96.2136   
 Negative Group 3   112.1032 112.1032  
 Extract 400mg/kg 
Group 
3   126.0888 126.0888  
 Extract 200mg/kg 
Group 
3    135.9413  
 Non treatment 
Group 
3     179.2439 
 Sig.  .220 .231 .171 .378 1.000 
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c) Ulcer healing 
i) Ulcer area 
Table 46. Descriptives: ulcer area of rats in ulcer treatment test 
 
 
Table 47. ANOVA: ulcer area of rats in ulcer treatment test 
 
 
 Sum of Squares df Mean Square F Sig. 
Between Groups 943704.000 3 314568.000 145.925 .000 
Within Groups 43113.600 20 2155.680   
Total 986817.600 23    
 
 
 
 
 
N Mean 
Std. 
Deviation 
Std. 
Error 
95% Confidence 
Interval for 
Mean 
Minimum Maximum 
Lower 
Bound 
Upper 
Bound 
Ulcer Control 
Group 
6 514.8000 70.36135 28.72490 440.9603 588.6397 403.20 590.40 
Omeprazole 
Group 
6 249.6000 56.07994 22.89454 190.7477 308.4523 158.40 324.00 
Hericium extract 
200mg/kg 
6 73.2000 22.95735 9.37230 49.1077 97.2923 43.20 108.00 
Hericium extract 
400mg/kg 
6 .0000 .00000 .00000 .0000 .0000 .00 .00 
Total 24 209.4000 207.13549 42.28136 121.9344 296.8656 .00 590.40 
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Table 48. Multiple range test: ulcer area of rats in ulcer treatment test 
 
 Group N Subset for alpha = 0.05 
   1 2 3 4 
Tukey HSD
a
 Hericium extract 
400mg/kg 6 .0000    
 Hericium extract 
200mg/kg 6 73.2000    
 Omeprazole Group 
6  249.6000   
 Ulcer Control Group 
6   514.8000  
 Sig.  .057 1.000 1.000  
 
 
Means for groups in homogeneous subsets are displayed. 
a. Uses Harmonic Mean Sample Size = 6.000. 
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ii) Mucus content 
 
Table 49. Descriptives: mucus content of rats in ulcer treatment test 
 
 
N Mean 
Std. 
Deviation 
Std. 
Error 
95% 
Confidence 
Interval for 
Mean Minimum Maximum 
Lower 
Bound 
Upper 
Bound 
Ulcer Control 
Group 
6 .2600 .11462 .04679 .1398 .3803 .11 .40 
Omeprazole 
Group 
6 .4813 .23871 .09745 .2308 .7318 .25 .92 
Hericium extract 
200mg/kg 
6 .2458 .08314 .03394 .1585 .3330 .10 .34 
Hericium extract 
400mg/kg 
6 .2790 .09066 .03701 .1839 .3742 .13 .38 
Total 24 .3165 .16770 .03423 .2457 .3873 .10 .92 
 
 
Table 50. ANOVA: mucus content of rats in ulcer treatment test 
 
 
 Sum of Squares df Mean Square F Sig. 
Between Groups .221 3 .074 3.449 .036 
Within Groups .426 20 .021   
Total .647 23    
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Table 51. Multiple range test: mucus content of rats in ulcer treatment test 
 
 Group N Subset for alpha = 0.05 
   1 2 
Tukey HSD
a
 Hericium extract 200mg/kg 6 .2458  
 Ulcer Control Group 6 .2600  
 Hericium extract 400mg/kg 6 .2790  
 Omeprazole Group 6 .4813  
 Sig. 
 
.050  
 
Means for groups in homogeneous subsets are displayed. 
a. Uses Harmonic Mean Sample Size = 6.000. 
 
iii) Alcian blue  
 
Table 52. Descriptives: alcian blue of rats in ulcer treatment test 
 
N Mean 
Std. 
Deviation 
Std. 
Error 
95% Confidence 
Interval for 
Mean 
Minimum Maximum 
Lower 
Bound 
Upper 
Bound 
Ulcer Control 
Group 
6 5.4173 .72640 .29655 4.6550 6.1796 4.39 6.47 
Omeprazole 
Group 
6 8.2568 2.13427 .87131 6.0170 10.4966 5.43 11.87 
Hericium 
extract 
200mg/kg 
6 7.5778 1.77778 .72577 5.7121 9.4434 5.73 10.32 
Hericium 
extract 
400mg/kg 
6 8.2938 .84154 .34356 7.4107 9.1770 7.06 9.65 
Total 24 7.3864 1.83833 .37525 6.6102 8.1627 4.39 11.87 
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Table 53. ANOVA: alcian blue of rats in ulcer treatment test 
 
 
 Sum of Squares df Mean Square F Sig. 
Between Groups 32.970 3 10.990 4.911 .010 
Within Groups 44.757 20 2.238   
Total 77.727 23    
 
 
Table 54. Multiple range tests: alcian blue of rats in ulcer treatment test 
 
 
 
Group N 
Subset for alpha = 0.05 
1 2 
Tukey HSD
a
 Ulcer Control Group 6 5.4173  
 Hericium extract 200mg/kg 6 7.5778 7.5778 
 Omeprazole Group 6  8.2568 
 Hericium extract 400mg/kg 6  8.2938 
 Sig. 
 
.090 .840 
 
Means for groups in homogeneous subsets are displayed. 
a. Uses Harmonic Mean Sample Size = 6.000. 
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Appendix C: Raw data 
a) Acute toxicity test 
Body weight of rats 
 
 
 
          Male                 Female         
    Control group   Low dose group   High dose group   Control group   Low dose group   High dose group 
Replicate 1st day 7th day 
14th 
day 1st day 7th day 
14th 
day 1st day 7th day 
14th 
day 1st day 7th day 
14th 
day 1st day 7th day 
14th 
day 1st day 7th day 
14th 
day 
1 279 305 313 242 263 270 245 282 283 205 219 212 210 205 214 168 174 180 
2 280 299 305 210 233 230 245 284 300 168 168 182 196 199 204 203 205 210 
3 230 255 269 230 250 255 280 319 325 188 178 185 222 225 226 212 222 219 
4 256 298 311 223 254 251 190 208 212 180 190 199 257 253 250 206 196 206 
5 190 230 241 240 261 270 176 203 204 164 167 175 225 233 240 202 211 221 
6 250 285 293 211 225 225 240 279 289 213 216 220 188 194 210 208 208 208 
154 
 
Hematological parameters 
HGB 
      
    Male     Female   
Replicate Control 
Low 
dose 
High 
dose Control 
Low 
dose 
High 
dose 
1 150 140 143 127 149 145 
2 135 151 150 141 138 147 
3 150 156 142 150 146 144 
4 147 160 150 148 130 135 
5 158 146 150 143 140 147 
6 144 151 135 137 89 147 
 
HCT 
      
    Male     Female   
Replicate Control 
Low 
dose 
High 
dose Control 
Low 
dose 
High 
dose 
1 0.47 0.45 0.47 0.42 0.5 0.48 
2 0.44 0.49 0.5 0.46 0.45 0.48 
3 0.49 0.5 0.47 0.5 0.48 0.48 
4 0.48 0.51 0.49 0.48 0.43 0.44 
5 0.52 0.47 0.49 0.49 0.46 0.49 
6 0.48 0.49 0.45 0.43 0.43 0.48 
 
RBC 
      
    Male     Female   
Replicate Control 
Low 
dose 
High 
dose Control 
Low 
dose 
High 
dose 
1 8.21 8.01 8.08 7 8.68 7.65 
2 7.9 8.36 8.8 8.16 8.04 8.11 
3 7.7 8.86 8.39 8.46 7.8 7.81 
4 8.51 9.27 8.56 8.31 7.4 7.51 
5 8.52 7.62 8.61 7.62 7.92 8.4 
6 8.24 8.26 7.9 7.27 7.22 8.4 
 
MCV 
      
    Male     Female   
Replicate Control 
Low 
dose 
High 
dose Control 
Low 
dose 
High 
dose 
1 57 56 58 60 57 63 
2 55 59 56 57 56 59 
3 64 57 56 59 61 62 
4 56 55 57 57 59 59 
5 61 62 57 64 58 58 
6 58 59 57 60 60 57 
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MCH 
      
    Male     Female   
Replicate Control 
Low 
dose 
High 
dose Control 
Low 
dose 
High 
dose 
1 18.3 17.5 17.7 18.1 17.2 19 
2 17.1 18.1 17 17.3 17.2 18.1 
3 19.5 17.6 16.9 17.7 18.7 18.4 
4 17.3 17.3 17.5 17.8 17.6 18 
5 18.5 19.2 17.4 18.8 17.7 17.5 
6 17.5 18.3 17.1 18.8 12.3 17.5 
 
MCHC 
      
    Male     Female   
Replicate Control 
Low 
dose 
High 
dose Control 
Low 
dose 
High 
dose 
1 320 311 306 304 301 302 
2 310 308 302 305 308 309 
3 305 311 302 301 305 299 
4 309 312 309 310 300 305 
5 304 311 307 293 306 300 
6 303 308 299 316 207 309 
 
RDW 
      
    Male     Female   
Replicate Control 
Low 
dose 
High 
dose Control 
Low 
dose 
High 
dose 
1 14.1 15.6 15.6 15.9 14.9 14.9 
2 14 14.2 16.3 14.7 13.9 14.1 
3 16.4 14.1 17.2 13.3 13.8 13.4 
4 15.5 16.4 15.7 16.8 13.7 13.5 
5 16.8 13.4 14.2 15 13.8 14.7 
6 17.4 14.9 17.1 14.6 13 13.4 
 
WBC 
      
    Male     Female   
Replicate Control 
Low 
dose 
High 
dose Control 
Low 
dose 
High 
dose 
1 5.1 7.3 7.1 2.8 5.8 5.4 
2 8.1 6 4.3 6.8 5.1 5.8 
3 8.7 7.1 6.9 4.8 4.2 7.8 
4 4.6 7.5 6.8 4.4 3 3.9 
5 6.6 9.3 7.1 4.3 5.4 5.5 
6 4.8 7.7 5.5 3.7 3 4.3 
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Platelet 
      
    Male     Female   
Replicate Control 
Low 
dose 
High 
dose Control 
Low 
dose 
High 
dose 
1 738 510 856 628 686 851 
2 806 675 834 821 901 741 
3 778 799 678 672 624 818 
4 814 818 686 654 702 633 
5 631 807 737 521 750 750 
6 789 819 749 546 483 680 
 
Renal function parameters 
Sodium 
      
    Male     Female   
Replicate Control 
Low 
dose 
High 
dose Control 
Low 
dose 
High 
dose 
1 140 142 143 142 141 142 
2 141 144 143 142 141 141 
3 144 141 142 140 142 142 
4 142 141 141 143 141 142 
5 143 143 143 142 138 141 
6 142 141 143 142 143 139 
 
Potassium 
     
    Male     Female   
Replicate Control 
Low 
dose 
High 
dose Control 
Low 
dose 
High 
dose 
1 4.6 4.9 5.5 4.3 4.9 4.3 
2 4.8 4.9 4.8 4.9 4.4 4.7 
3 4.8 5.2 5.1 4.8 4.9 4.7 
4 4.6 5.3 5.1 4.7 3.9 4.3 
5 4.8 4.9 5 4.8 4.8 4.7 
6 5 5.3 5 4.2 4.5 4.5 
 
Chloride 
      
    Male     Female   
Replicate Control 
Low 
dose 
High 
dose Control 
Low 
dose 
High 
dose 
1 101 108 107 105 104 106 
2 103 107 102 107 104 105 
3 106 102 103 103 106 106 
4 103 105 107 106 106 109 
5 106 109 106 104 104 105 
6 105 107 106 107 108 105 
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CO2 
      
    Male     Female   
Replicate Control 
Low 
dose 
High 
dose Control 
Low 
dose 
High 
dose 
1 26.3 20.9 24.4 23.8 24.1 24.1 
2 25.1 23.1 26.9 21.9 23.7 23.3 
3 25 27.8 26 24.1 22.2 21.8 
4 25.1 22.2 19.9 22.9 21.5 18.6 
5 22.3 19.2 22.5 24.6 22.6 22.3 
6 25.1 22.4 23.8 22.7 23.6 21.6 
 
Anion gap 
     
    Male     Female   
Replicate Control 
Low 
dose 
High 
dose Control 
Low 
dose 
High 
dose 
1 17 18 17 18 18 16 
2 18 19 19 18 18 17 
3 16 16 18 18 19 19 
4 19 19 19 19 17 19 
5 20 20 20 18 16 18 
6 17 17 18 17 16 17 
 
Urea 
      
    Male     Female   
Replicate Control 
Low 
dose 
High 
dose Control 
Low 
dose 
High 
dose 
1 4.6 7.5 5.7 7.2 7.1 11.3 
2 4.9 7 5.2 8.6 7.8 8 
3 4.4 4.4 6.2 6.8 8.3 7.3 
4 5.5 5 6.1 8.7 8.2 8.9 
5 6.8 6.4 5.4 8.1 8.4 7.5 
6 5 6.9 5.2 8.2 8 6.8 
 
Creatinine 
     
    Male     Female   
Replicate Control 
Low 
dose 
High 
dose Control 
Low 
dose 
High 
dose 
1 33 42 40 36 34 40 
2 44 40 42 43 42 45 
3 30 36 46 39 62 44 
4 29 26 17 54 36 48 
5 35 29 21 37 48 35 
6 38 29 40 37 30 36 
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Liver function parameter 
Total protein 
     
    Male     Female   
Replicate Control 
Low 
dose 
High 
dose Control 
Low 
dose 
High 
dose 
1 66 58 61 65 65 67 
2 61 58 62 61 67 64 
3 58 58 63 69 64 64 
4 59 60 60 66 61 67 
5 62 58 59 64 59 65 
6 62 55 56 61 64 63 
 
Albumin 
      
    Male     Female   
Replicate Control 
Low 
dose 
High 
dose Control 
Low 
dose 
High 
dose 
1 11 10 11 11 11 11 
2 8 9 11 11 10 10 
3 10 8 8 11 13 12 
4 10 9 10 11 10 13 
5 11 8 10 12 11 11 
6 9 8 9 11 11 12 
 
Globulin 
      
    Male     Female   
Replicate Control 
Low 
dose 
High 
dose Control 
Low 
dose 
High 
dose 
1 55 48 50 54 54 56 
2 53 49 51 50 57 54 
3 48 50 55 58 51 52 
4 49 51 50 55 51 54 
5 51 50 49 52 48 54 
6 53 47 47 50 53 51 
 
Total bilirubin 
     
    Male     Female   
Replicate Control 
Low 
dose 
High 
dose Control 
Low 
dose 
High 
dose 
1 2 2 2 2 2 2 
2 2 2 2 2 2 2 
3 2 1 2 2 2 2 
4 2 2 2 2 2 2 
5 2 2 2 2 2 2 
6 3 2 2 2 2 2 
 
 
 
 
 
159 
 
Conjugated bilirubin 
    
    Male     Female   
Replicate Control 
Low 
dose 
High 
dose Control 
Low 
dose 
High 
dose 
1 1 1 1 1 1 1 
2 1 1 1 1 1 1 
3 1 1 1 1 1 1 
4 1 1 1 1 1 1 
5 1 1 1 1 1 1 
6 1 1 1 1 1 1 
 
ALP 
      
    Male     Female   
Replicate Control 
Low 
dose 
High 
dose Control 
Low 
dose 
High 
dose 
1 106 146 124 107 89 125 
2 200 137 114 107 79 75 
3 170 155 178 159 53 101 
4 155 124 131 112 74 88 
5 175 223 131 120 64 83 
6 112 194 132 84 78 92 
 
ALT 
      
    Male     Female   
Replicate Control 
Low 
dose 
High 
dose Control 
Low 
dose 
High 
dose 
1 58 48 44 43 49 47 
2 55 47 50 40 46 44 
3 53 49 50 37 37 47 
4 52 48 44 45 37 44 
5 48 50 42 51 31 36 
6 45 46 49 43 38 49 
 
AST 
      
    Male     Female   
Replicate Control 
Low 
dose 
High 
dose Control 
Low 
dose 
High 
dose 
1 155 182 190 177 146 190 
2 201 169 159 177 202 201 
3 173 163 208 142 197 160 
4 159 193 165 168 153 187 
5 160 197 153 193 150 180 
6 181 187 180 171 185 179 
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GGT 
      
    Male     Female   
Replicate Control 
Low 
dose 
High 
dose Control 
Low 
dose 
High 
dose 
1 3 3 3 3 3 3 
2 4 3 3 5 3 3 
3 3 5 3 3 6 3 
4 3 3 3 4 3 3 
5 3 3 3 3 3 3 
6 3 5 4 4 3 3 
 
a) Anti-ulcerogenic study 
 
      
ulcer 
area       
 
Normal 
group 
Ulcer 
control 
group 
Omeprazole 
group 
Extract 
50mg/kg 
Extract 
100mg/kg 
Extract 
200mg/kg 
Extract 
400mg/kg 
1 0 864 252 792 504 496.8 237.6 
2 0 842.4 280.8 640.8 633.6 396 172.8 
3 0 936 316.8 669.6 720 367.2 208.8 
4 0 756 360 712.8 583.2 525.6 273.6 
5 0 993.6 223.2 741.6 604.8 518.4 280.8 
6 0 972 280.8 806.4 568.8 417.6 266.4 
 
 
      
mucus 
content       
 
Normal 
group 
Ulcer 
control 
group 
Omeprazole 
group 
Extract 
50mg/kg 
Extract 
100mg/kg 
Extract 
200mg/kg 
Extract 
400mg/kg 
1 0.4135 0.7234 1.535 0.7566 0.8121 1.1464 1.3231 
2 0.5908 0.8542 1.453 0.8592 0.9283 0.7588 1.0424 
3 0.2057 0.6956 1.488 0.7984 0.8358 0.8571 1.2194 
4 0.5554 0.7947 1.367 0.6982 0.6398 0.9478 1.1172 
5 0.3385 0.8869 1.848 0.8983 0.8441 1.0493 1.1712 
6 0.4586 0.8378 1.643 0.7659 0.8642 0.7999 1.2263 
 
 
      
Alcian 
blue       
 
Normal 
group 
Ulcer 
control 
group 
Omeprazole 
group 
Extract 
50mg/kg 
Extract 
100mg/kg 
Extract 
200mg/kg 
Extract 
400mg/kg 
1 3.207407 3.42963 5.355556 6.17037 10.54074 11.5037 13.57778 
2 5.8 3.503704 9.133333 10.24444 9.874074 11.65185 11.13333 
3 4.17 2.837037 7.725926 8.096296 12.76296 13.28148 8.392593 
4 6.096296 3.503704 7.503704 9.948148 11.8 13.28148 12.83704 
5 5.8 3.42963 4.911111 6.466667 11.8 10.02222 8.911111 
6 4.985185 3.8 5.725926 7.651852 10.39259 14.02222 8.985185 
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      MDA       
 
Normal 
group 
Ulcer 
control 
group 
Omeprazole 
group 
Extract 
50mg/kg 
Extract 
100mg/kg 
Extract 
200mg/kg 
Extract 
400mg/kg 
1 4.52657 9.067633 5.299517 7.183575 6.555556 5.7343 5.10628 
2 4.478261 8.729469 5.637681 7.47343 7.038647 6.217391 5.299517 
3 4.285024 8.874396 5.396135 7.714976 6.89372 6.120773 5.347826 
 
 
      SOD       
 
Normal 
group 
Ulcer 
control 
group 
Omeprazole 
group 
Extract 
50mg/kg 
Extract 
100mg/kg 
Extract 
200mg/kg 
Extract 
400mg/kg 
1 8.260235 1.642295 5.369144 2.011252 5.029921 6.310204 5.691669 
2 9.328042 2.198369 5.976743 1.904177 4.080923 5.536923 5.470084 
3 8.860137 1.826241 5.964269 2.394101 3.950272 6.869823 4.78879 
 
 
      CAT       
 
Normal 
group 
Ulcer 
control 
group 
Omeprazole 
group 
Extract 
50mg/kg 
Extract 
100mg/kg 
Extract 
200mg/kg 
Extract 
400mg/kg 
1 166.6071982 106.9345816 62.31956884 37.89692563 83.11101505 146.2662149 130.218007 
2 203.011208 129.295061 75.3200287 45.8620604 117.263649 123.838596 133.489721 
3 168.113376 100.079893 67.9043941 37.5977055 88.2662547 137.71901 114.558563 
 
b) Ulcer healing 
 
    ulcer area     
 
Normal control 
group 
Ulcer control 
group 
Omeprazole 
group 
Extract 
200mg/kg 
Extract 
400mg/kg 
1 1411.2 468 230.4 108 0 
2 1310.4 511.2 324 64.8 0 
3 1238.4 403.2 244.8 57.6 0 
4 1706.4 590.4 158.4 86.4 0 
5 1591.2 576 252 43.2 0 
6 1360.8 540 288 79.2 0 
 
 
    
mucus 
content     
 
Normal control 
group 
Ulcer control 
group 
Omeprazole 
group 
Extract 
200mg/kg 
Extract 
400mg/kg 
1 0.5688 0.2532 0.9156 0.2438 0.3245 
2 0.5796 0.1475 0.5166 0.2251 0.2113 
3 0.5416 0.1053 0.4795 0.2543 0.3378 
4 0.7504 0.3066 0.248 0.3364 0.134 
5 0.3833 0.3517 0.283 0.1005 0.2881 
6 0.5266 0.3959 0.4452 0.3146 0.3784 
 
 
    Gastric mucus barrier   
 
Normal control 
group 
Ulcer control 
group 
Omeprazole 
group 
Extract 
200mg/kg 
Extract 
400mg/kg 
1 16.39259 6.466667 9.059259 10.31852 8.17037 
2 14.83704 5.948148 11.87407 6.17037 9.651852 
3 11.13333 4.392593 7.355556 9.059259 8.096296 
4 10.0963 5.42963 5.42963 5.725926 7.059259 
5 10.17037 4.985185 7.948148 6.762963 8.17037 
6 12.24444 5.281481 7.874074 7.42963 8.614815 
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